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THE EFFECTS OF GONADOTROPIC HORMONES ON ADRENAL FUNCTION 
IN THE MALE PSEUDOHERMAPHRODITE RAT
CHAPTER I 
INTRODUCTION
The great variety of sexual characters and the pronounced sexual 
dimorphism found among many living forms have always intrigued the imag­
ination of biologists. Indeed, much, of the biological advancement in 
the area of reproductive physiology can be attributed to the peculiar, 
disparate or divergent sexual states existing in nature. These states 
have led to inquiries which have produced a greater understanding of 
reproductive systems and related phenomena. The present work was under­
taken because an apparent hermaphroditic condition was found to exist 
in the laboratory rat which did not conform to current endocrinologie 
concepts.
The aim of this dissertation is to define and quantitate the 
factors involved in adrenal enlargement and hyperfunction of the adrenal 
androgen biosynthetic pathway in the male pseudohermaphrodite rat.■ It 
is hoped that the conclusions drawn will be more far-reaching than simply 
the elucidation of this anomaly.
Historical Review: the Endocrinology
of Reproduction
Although the scope of this dissertation is centered on a small 
segment of reproductive physiology, the methods employed and conclusions 
drawn were dependent on concepts encompassing the entire field. It seems 
therefore quite appropriate to review, briefly, the development of basic 
concepts of reproductive physiology which have made this research possible.
The endocrinology of reproduction had its inception in the mid- 
1800's when Berthold (1849) demonstrated the existence of an internal se­
cretion in the gonads by means of testis transplants in capons. However, 
the dependence of the internal secretion of the gonads upon the pituitary 
was not to be uncovered for another 50 years. In 1908, Paulesco first 
described gonadal atrophy following hypophysectomy. Two years later.
Crow, Cushing and Homans (1910) reported amelioration of gonadal atrophy 
after hypophysectomy by pituitary implants. Regulation of gonadal func­
tion by pituitary hormones was firmly established as a result of the sep­
arate investigations of Smith (1927), Smith and Engle (1927), and of 
Aschheim and Zondek (1927) and Zondek (1927). During the 1920's, it was 
also learned that gonadal hormones modify hypophyseal secretion of gonad­
otropic hormones. A reciprocal relationship between the pituitary and 
gonads was first suggested by Engle in 1929. A correlation of the gonad­
otropic activity of the pituitary and the stage of the estrous cycle was 
made by Smith and Engle (1929) during this same period of time. They 
found that the guinea pig pituitary was less potent during estrus than 
during diestrus. Engle (1929) and Evans and Simpson (1929) reported that 
the gonadotropic hormones of the anterior lobe of gonadectomizec animals
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increased in potency following castration. Engle suggested that the 
gonads affected the release of gonadotropins from the pituitary and thus 
in the absence of the gonads the gonadotropic hormones were stored. In 
1927, Kallas reported that if a normal immature female rat was surgically 
united in parabiosis with an immature castrated rat, the normal twin came 
to precocious sexual maturity, indicating a marked increase in pituitary 
secretion following castration. Kallas was also able to prevent the in­
creased gonadotropic activity of the castrate partner by injecting estro­
gen into the castrate animal. Shortly thereafter, Moore and Price (1932) 
reported that the deleterious effects of estrogens and androgens on the 
testes and ovaries did not appear if a gonadotropic extract were inject­
ed simultaneously with the gonadal hormones. From this experiment they 
concluded that the gonadal hormones did not have a harmful effect on the 
gonads, but inhibited the secretion of gonadotropic hormones by the pit­
uitary with the result that the gonads became atrophic.
Evidence for the secretion of a follicle-stimulating hormone as 
a separate factor from the luteinizing hormone was first shown by Aschheim 
and Zondek in 1927 and by Zondek in 1930. Fractionation of the pituitary 
gonadotropic extracts into follicle-stimulating hormone and luteinizing 
hormone was first accomplished by Fevold, Hisaw, and Leonard in 1931,
The fractionation of pituitary extracts into two separate and active con­
stituents created a necessity for a definitive assay procedure for deter­
mining the completeness and potency of such fractions. This necessity 
ushered in the era of biological assays.
Knauer (1900) and Halban (1900) repeated Berthold's work on 
female rabbits and guinea pigs. Both concluded that the ovary exerted
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an influence on the uterus through the medium of an internal secretion, 
Following the important work of Knauer and Halban, Adler, in 1912, pre­
pared extracts from the ovary of sows which produced hypertrophy of the 
uterus. Stimulated by the pioneer work of Allen and Doisy in 1923 on the 
bioassay of the ovarian estrogenic substances and by the discovery of 
Aschheim and Zondek in 1927 of the presence of large amounts of estrogen­
ic material in the urine of pregnant women, the stage was set for isola­
tion and characterization of sex steroids as cyclopentanophenanthrene 
derivatives. The substance we now know as estrone, was isolated from 
human pregnancy urine in a crystalline state simultaneously by Doisy, 
Veler and Thayer (1929), Butenandt (1929) and Dingemanse e_t â . (1930).
In 1930, a second crystalline estrogen, estriol, was isolated by Marrian 
and by Doisy e_t After the sterol-bile acid formula had been pro­
posed by Rosenheim and King in 1932, the likelihood that steroids were 
phenanthrene derivatives occurred to many investigators. This likelihood 
became a certainty when Butenandt, Weidlich and Thompson (1933) proved 
the estrogens to be phenanthrene derivatives. Complete proof of the 
structures of the natural estrogens was achieved largely as a result of 
the work of Cohen and his collaborators (1934; 1935). This work was fac­
ilitated by a new extraction procedure devised by Girard and Sandulasco 
(1936) for obtaining pure estrogens in high yield. Girard and his collab­
orators extracted large quantities of urine with an organic solvent and 
then used a compound (chloride of trimethylaminoacito-hydrazine) which 
reacts with ketones to render them soluble in water.
Perhaps the most remarkable achievement in all this early work 
on the estrogenic substances was the isolation of estradiol-173 from the
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liquor folliculi of sow ovaries by MacCorquodale, Thayer and Doisy in 
1936. The amount of estrogen stored in the ovary is so small that 400 
liters of liquor folliculi were processed in order to obtain the few 
milligrams of crystalline substance necessary for characterization.
The modern concepts of the hormonal action of the corpus luteum 
originated in part from experiments carried out by Fraenkel in 1903. He 
showed that removal of the corpus luteum in the first few days of preg­
nancy caused the embryos to disappear. Perhaps the first theory of func­
tion of the corpus luteum to receive support from later investigations 
was that it might exercise an inhibitory influence on ovulation. The 
theory of inhibition of estrus was tested experimentally by Loeb in 
1911, who demonstrated that in guinea pigs removal of the corpora lutea 
accelerated the next ovulation. Bouin and Ancel in 1909 were the first 
to demonstrate that the corpora lutea were responsible for the progesta­
tional changes in the rabbit uterus. They showed that the removal of 
the corpora lutea by excision prevented formation of the progestational 
condition. Hence the classical observations of Fraenkel, Loeb, and 
Bouin and Ancel established the corpus luteum as an endocrine gland whose 
primary function was to prepare the uterus for implantation of the fert­
ilized ovum.
Clear-cut evidence for the presence in extracts of the corpus 
luteum of a principle active in producing progestational changes in the 
uterus was obtained by Comer (1929) and by Allen (1930). Six years 
later the isolation of this active principle as a pure crystalline sub­
stance was reported simultaneously by Butenandt and Westphal (1934),
Allen and Wintersteiner (1934), Slotta, Ruschig and Pels (1934) and by
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Hartman and Wettstein (1934). The complete structure of progesterone was 
elucidated by Butenandt and Westphal (1934) and Independently by Fernholz 
(1934). Pregnanediol, which later was to assume a position of some import­
ance in the progesterone story, had originally been isolated from human 
pregnancy urine by Marrian in 1929. Shortly thereafter Butenandt (1930) 
established the correct molecular formula. The possible biochemical sig­
nificance of pregnanediol, although quite obscure at the time of its first 
isolation, became apparent as soon as the molecular formula and chemical 
nature of progesterone were established. Final proof of the metabolic re­
lationship between pregnanediol, the excretory metabolite of progester­
one, and progesterone was obtained by Venning and Bro\me in 1937, They 
were able to show that during the menstrual cycle, pregnanediol was excret­
ed in the urine only during the luteal phase of the cycle.
The foundation was laid for the extraction and characterization 
of the androgens with the discovery by McGee, Juhn and Doram (1928) that 
a lipid concentrate from the testes of bulls produced a growth response 
in the combs of capons. The first pure crystalline androgen was obtain­
ed not from the testis, however, but from urine. In 1928, Loewe et al. 
reported the presence of an androgenic substance in human male urine, 
and six years later Butenandt and Tscherning (1934a; 1934b) and Ruzicka 
et al. (1934; 1935) were successful in isolating an active saturated hydro- 
xyketone, androsterone, from this source. A second crystalline androgen, 
dehydroepiandrosterone, was isolated from human urine by Butenandt and 
Dannerbaum in 1934. Finally, in 1935 the testicular androgen was isolat­
ed as a pure crystalline substance by David, Dingemanse and Laqueur and 
named testosterone. Almost immediately afterward, testosterone was
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obtained by a series of transformations, using dehydroepiandrosterone 
as a starting material, by Butenandt and Gunter (1935) and by Ruzicka 
and Wettstein (1935).
In 1934, Reichstein isolated a crystalline substance from the ad­
renal cortex, adrenosterone, which was subsequently shown to be a C^q 
compound possessing androgenic potency. This fact, together with the 
fact that certain of the C21 compounds could be degraded to androgenic 
compounds led Reichstein to suggest that the adrenocortical substance 
might be similar in structure to the sex steroids. Research on the urin­
ary androgens and the other related neutral 17-ketosteroids was greatly 
facilitated by the well-known colorimetric method which was first sug­
gested by Zimmermann in 1935. Many modifications in the Zimmermann meth­
od have since been made. Nevertheless, it seems clear that the chief 
credit for first developing a reliable and accurate method for assaying 
urinary ]7-ketosteroids must be given to Zimmermann,
Male Pseudohermaphroditism: Description of
Genotype and Phenotype in the Rat and Man
Male pseudohermaphroditism is a sexual condition characterized 
by a disparity between the genotype and phenotype of a male individual 
A defect involving responsiveness of somatic tissues to androgens is the 
primary lesion which produces this anomaly (Morris and Mahesh, 1963). 
Genetic study of this anomaly in the rat began with the discovery by- 
Stanley and Gumbreck (1964) of a single litter of Fg King x Holtzman 
hybrid rats. This litter was born of parents of normal phenotype and 
contained 1 normal male, 5 females and 2 pseudohermaphrodites. From this 
single litter a colony has been established- If only the litters contain­
ing all three types are considered, a recent sample of 210 litters
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comprising a total of 1364 animals contains 620 females, 372 males and 
372 male pseudohermaphroditesc Inspection of the above figures shows 
that the defect is found in half of the males in litters in which it oc­
curs. This is the classical ratio produced by a sex-linked gene.
When dams that had produced pseudohermaphrodites were outbred to 
males of an unrelated line, the ratio of normal males to male pseudoher­
maphrodites was still 1:1 Of such matings there were 26 litters contain­
ing 160 animals: 71 females, ^4 males and 45 male pseudohermaphrodites.
IThen sires of pseudohermaphrodites were outbred to females of an unrelat­
ed line there were no pseudohermaphrodites produced. In 19 such litters, 
there was a total of 15 2 animals: 85 normal females and 67 males with no
pseudohermaphrodites. Thus, these data show that only the female trans­
mits the defect. Since male offspring obtain their single X chromosome 
only from their mothers and since there are the two classes of males, 
normal and pseudohermaphrodites in equal numbers, the gene for this trait 
must be carried on the X chromosome- According to Castle and King (1940) 
there are now five well established linkage groups for the rat and none 
of the known genes thus far mapped occurs in association with the gene 
for pseudohermaphroditism. Its sporadic occurrence in widely separated 
general populations such as that of the mouse, pig, goat, rat and man 
would seem to indicate that a normal gene must mutate with some regular­
ity to product it.
Since pseudohermaphrodites are all sterile and cannot therefore 
transmit the gene for the defect, it cannot be said with certainty that 
this gene is either a dominant or a recessive one- There seems to be no 
logical alternative over that of a single sex-linked recessive. Evidence
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now at hand proving that these aniirals are genetic males consists of the 
following facts:
1) The nuclei of liver cells of pseudohermaphrodites are 
chromatin negative as in normal male littermates, while 
Barr bodies are clearly observed in nuclei of liver cells 
of female littermates (Allison, Stanley and Gumbreck, 1964).
2) The karyotype of the pseudohermaphrodite is the same as that
of normal males, both showing in particular a single X and Y
chromosome (Allison, Stanley and Gumbreck, 1964).
3) The sex ratios among offspring indicate that these animals 
are genetic males (Stanley and Gumbreck, 1964).
In affected animals the entire reproductive tract, with the ex­
ception of small bilateral testes, is missing. These testes usually lie 
in the perineal region and since there is no scrotum they can only des­
cend through the inguinal ring to a position just outside the body cavity. 
The possibility of high temperature damage to these gonads exists and may 
account partially for the failure of spermatogenesis to occur. Occasion­
ally one or both of these testes will remain inside the body cavity.
Nipples are formed along the milk line in the same number and 
position as in the female. They become visible at an early age and al­
though the amount of growth does not approach that of the female they can 
be easily seen throughout the life of the animal. A vaginal opening is 
patent but small in about 50 per cent of the affected animals, being only 
1 to 2 millimeters in depth and ending in a blind cul de sac- The other 
half of the affected animals exhibits only a scar which is completely 
closed but visible in what would be the vaginal position in a female.
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indicating late closure of the embryonal raphe (Stanley and Gumbreck,
1964). Affected animals resemble females in early life and the difference 
in external genitalia and nipple line are not readily apparent at birth. 
Even at 21 days of age, it is often difficult to identify a pseudohermaph­
rodite with certainty (APPENDIX I, Page 129). Body size and weight of 
the adult animals are intermediate between those of normal males and fe­
males. The average weight of 15 normal females of the strain is 239 grams, 
that of 15 males 415 grams, while that of 15 male pseudohermaphrodites is 
318 grams. Significant difference in the wet weights of some of the endo­
crine glands is also seen. The pituitary and adrenal glands of the pseudo­
hermaphrodites are significantly larger than those of normal males and 
females. The kidneys are also significantly smaller in size and weight 
than those of either normal males or females on the basis of body weight. 
The kidney weight/body weight ratio for normal males is .0067, for normal 
females .0068 and for the pseudohermaphrodites .0062. APPENDIX II (Page 
135) lists the comparative organ weights for males, females and pseudoher­
maphrodites .
Sterility in the pseudnhermaphrodite is rather obviously reflect­
ed in the histological picture of the testes. In most of the seminifer­
ous tubules, the germinal epithelium consists of a thin layer, one or 
two cells in thickness. The cell types consist of spermatogonia, Sertoli 
cells and usually some large primary spermatocytes (APPENDIX I, Page 130 ). 
Secondary spermatocytes, spermatids and spermatozoa are never observed.
In contrast to the germinal line, there is a marked hyperplasia of the 
interstitial cells of Leydig (APPENDIX I, Page 131). In a large proportion 
of the older pseudohermaphrodites, one and occasionally both of the testes
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develop Sertoli cell tumors- Some of these become quite large weighing 
up to 10 grams. The testicular neoplasms vary considerably in structure 
from area to area. Some sections reveal a peripheral rim of seminiferous 
tubules which are lined by Sertoli cells showing moderate to marked hy­
perplasia. This testicular tissue then merges into neoplastic tissue- 
The neoplasm varies from areas in which there is a tubular arrangement 
associated with an overgrowth of Sertoli cells, while in other areas 
there are islands of cells which are generally polygonal in shape and 
appear to be finely vacuolated- Many areas, however, are characterized 
by spindle-shaped cells which have a whorled appearance. In these areas 
there is no resemblence co parent tissue. No crystalloids of Reinke or ^ 
lipochrome pigment are ever encountered (APPENDIX I, Page 132-133).
The time and site of action of the gene which produces pseudo­
hermaphroditism have now been established. By removal of embryos at 
different stages of development from pregnant mothers that had produced 
one or more litters containing pseudohermaphrodites, Allison (1956) found 
that the reproductive tract began to degenerate by day 17 of the pregnan­
cy and by day 19 all vestiges of it had completely disappeared, with only 
the testes remaining. The anlage for the ductal and accessory systems 
were present and appeared to be normal until day 17 _in utero. Regression 
appeared to be under way at day 17 and was complete by day 19 _in utero.
In order to understand the significance of this anomaly, reference 
must be made to the work of Jost (1958). Using the rabbit as an experi­
mental model, Jost castrated embryos of pregnant females before day 19 
in utero. He found that castration did not have any adverse effect on 
the subsequent development of the female reproductive tract of castrated
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female embryos. In marked contrast to the females, castrated males 
developed a complete female reproductive tract. This classical experi­
ment demonstrated the necessity of the presence of the testes for the 
masculinization of the male reproductive anlage. To go one step further, 
Jost transplanted unilaterally a testis into the vicinity of the develop­
ing reproductive anlage of female embryos. On the operated side of the 
females, the Mullerian anlagen (female counterpart) were inhibited and 
the Wolffian (male counterpart) derivative developed. On the intact con­
tralateral side, the Mullerian anlagen developed as expected.
The results of the work of Jost offer a functional explanation 
for the absence of the reproductive tract in the male pseudohermaphrodite. 
The Wolffian or male counterpart of the reproductive tract does not de­
velop because pseudohermaphrodites are insensitive to androgens. Conse­
quently, the pseudohermaphrodite cannot induce formation of a male repro­
ductive system. Furthermore, the Mullerian or female counterpart of the 
reproductive tract does not develop because the testes inhibit development 
of the female anlage. Hence, the net result is a complete absence of the 
reproductive tract of either male or female origin.
In 1953, Morris suggested the term "testicular feminization" for 
an hereditary syndrome occurring in man, characterized by individuals 
with testes but otherwise female phenotype. These individuals have 
complete female urogenital sinus derivatives, lack development of both 
Mullerian and "Wolffian duct systems and exhibit female secondary sex 
characteristics. The syndrome is hereditary with transmission through 
the maternal line. The carriers are usually normal females, but decreas­
ed axillary hair or pubic hair has been noted in otherwise normal mothers.
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Jacobs et al. (1959) and Puck, Robinson and Tijo (1960) have found the 
sex chromosome complement in cases of this syndrome to be XY. Others have 
confirmed this finding (Bergada et al., 1962; Allexander and Ferguson- 
Smith, 1961). Crumbach and Barr (1958) have pointed out that the ratio 
of female to male to affected male approximates 2:1:1 leading to the con­
clusion that this syndrome is either a sex-linked recessive trait or a 
sex-limited autosomal dominant one.
In man, the term "testicular feminization" has been inappropriate­
ly applied to cases exhibiting clitoral enlargement. In the "complete" 
form of the syndrome the clitoris is normal or small. Undoubtedly, there 
may be some with minimal clitoral enlargement who present a closely re­
lated anomaly, especially when associated with female secondary sex charac­
teristics. There may be a similar hereditary etiology, but secondary 
sex characteristics even-with slight enlargement of the clitoris are un­
predictable. They may resemble the complete form of feminization and in 
such instances probably have a similar etiology, they may be essentially 
males, they may be intermediate with sexual hair and breast development, 
or they may have no pubic hair and no breast development (Morris, 1953). 
While both syndromes are hereditary, the complete feminization syndrome 
and the syndrome with clitoral enlargement do not occur in the same 
family tree (Morris and Mahesh, 1963). Because the secondary sexual 
characteristics and the genital abnormalities vary, cases with clitoral 
enlargement should be considered as separate. Any attempt at comparison 
between pseudohermaphroditism in man and the rat is extremely hazardous, 
unless the complete form in the human is well established.
The histological picture of the testes in human pseudohermaphro­
dites closely resembles that occurring in the rat. There is a predominance
14
of tubules containing mature Sertoli cells (Morris and Mahesh, 1963; 
David al., 1963; Kase and Morris,1965). The tubules appear to be
lined principally by germ cells in association with the Sertoli cells. 
The occurrence of large aggregates of Leydig cells bears an amazing re­
semblance to Leydig cell hyperplasia found in male pseudohermaphrodite 
rats. The incidence of neoplasia in these gonads is difficult to ascer­
tain, since the majority of cases reported in the literature have only 
reached their late teens.
Male Pseudohermaphroditism: Endocrine Aspects
in the Rat and Man
The similarity of male pseudohermaphroditism in the rat to that 
in man is striking in several aspects, one of the most interesting being 
the lack of response of somatic and sexual tissue to administered andro­
gens. Notable in the rat is the lack of effect of testosterone on the 
kidney, as well as the urinary papilla which shows no stimulation by 
growth or even hyperemia (Stanley, Gumbreck and Easley, 1966). The posi­
tive growth effect of testosterone on the kidney of the normal rat has 
been well documented (Korenchevsky and Ross, 1940). The presence of 
high urinary 17-ketosteroid levels in human pseudohermaphrodites with 
absence of body hair suggested to Wilkins (1957) that the disorder might 
be due to a peripheral lack of responsiveness to androgens. This hypo­
thesis was supported by his observation that large doses of methyl 
testosterone caused no growth of sexual hair, enlargement of the clitoris 
or change in voice. These studies have not established whether the de­
fect is due to an end organ refractoriness to androgen, to the formation 
of an androgen inhibitor or to nerinheral conversion of androgens to
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estrogens,
It has been amply demonstrated that testosterone is an anabolic 
agent capable of bringing about a positive nitrogen balance (Brown and 
Samuels, 1956; Kenyon et al., 1940; Knowlton _et , 1942; Landau et al., 
1950). Iften food intake is held constant, urinary nitrogen decreases.
In addition, there is a similar fall in urinary phosphorus. The finding 
that patients with the complete form of testicular feminization fail to 
show this anabolic response when treated with large doses of testosterone 
supports the hypothesis of somatic tissue refractoriness and indicates 
that the defect involves the anabolic as well as the virilizing effects 
of the hormone (French _et al., 1966)- The urinary excretion of citrate 
has been shown by Short, e_t aJ. (1948) to decrease after treatment with 
testosterone. This effect of testosterone appears to be the result of 
an increased renal tubular reabsorption of citrate. The lack of this 
response in human pseudohermaphrodites makes it appear that the somatic 
tissue defect in the complete form of so-called testicular feminization 
encompasses all effects of the hormone (French _et al̂- , 1966).
Endocrine studies performed on patients with this syndrome have 
in general shown normal or elevated levels of urinary 17-ketosteroids, 
female levels of urinary estrogens, cornification of the vaginal mucosa 
and elevated gonadotropins. With castration there has been reported a 
fall in 17-ketosteroids and estrogens, decrease in vaginal cornification 
and a rise in gonadotropins indicating at least in part a gonadal hormone 
source. Stimulated by studies such as those summarized above, Stanley 
and co-workers (1967) reported steroid determinations of the plasma of 
male pseudohermaphrodite rats- The titers of the three estrogens, estrone.
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escriol and estradiol-17S in the pseudohermaphrodice rats were approxi­
mately double those of their normal male controls. Dehydroepiandrosterone 
was about 6 times greater in plasma of pseudohermaphrodites than in that 
of normal male controls, while androsterone values were equal in both. 
Adrenosterone and etiocholanolone were between 2 and 3 times as great in 
pseudohermaphrodites as in the controls. APPENDIX II (Page 136) summari­
zes the above results. These values indicate some similarity between 
this syndrome in the rat and male pseudohermaphroditism with feminizing 
testes in man. David ^  al_. (1965) have also reported a marked increase 
of urinary dehydroepiandrosterone in human pseudohermaphrodites. Normally 
the testes secrete little or no dehydroepiandrosterone, the adrenal being 
the chief contributor to this neutral 17-ketosteroid. In vitro studies 
of human pseudohermaphrodite testes demonstrate two biosynthetic pathways 
to testosterone, one from 56 pregnenolone via 17-hydroxypregnenolone and 
dehydroepiandrosterone and a second via progesterone and 17-hydroxypro- 
gesterone (David et al., 1965; Green, Miller and Hamwi, 1963). The fact 
that urinary dehydroepiandrosterone of testicular origin is negligible 
in normal men and is present in significant quantity in rats and patients 
with this syndrome supports the view that the preponderance of the former 
pathway is an unusual finding that may be of significance in the etiology 
of this syndrome.
In human pseudohermaphrodites, measurement of urinary steroids 
before and after castration have shown that the testes make a significant 
contribution to the urinary 17-ketosteroids and estrogens (Ikkos, Tillin- 
ger and Westman, 1959; Salassa et al., 1961; Morris, 1953). The ability 
of testis slices to synthesize estradiol-173 from labeled progesterone
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and testosterone is consistent with the higher concentration of estrogen 
in testicular venous blood (French et_ al., 1965; Griffiths, Grant and 
IThyte, 1963). French et al., (1965) reported that the concentration of 
estradiol-173 in testicular venous blood of human pseudohermaphrodites 
was about 25 times greater than in peripheral blood and peripheral blood 
values were in the normal female range. Urinary 17-ketosteroid and 17- 
hydroxy cor ticosteroid excretion of human pseudohermaphrodites were within 
the normal limits for both males and females (David ̂  , 1963; French
_et_ , 1965; Griffiths, Grant and Whyte, 1963; Ikkos, Tillinger and 
Westman, 1959; Molinoff and Armstrong, 1962; Morris and Mahesh, 1963; 
Salassa _et ,1961). The significant drop in urinary 17-ketosteroids 
following gonadectomy indicates that the testes contribute approximately 
one-fourth the initial control level (French _e£ ̂ .  , 1965). The high 
blood levels of testosterone support the view that lack of virilization 
in these patients is not due to a deficient production of testosterone.
The results obtained from progesterone-4-^^C incubation studies serve to 
indicate that the testes are capable of producing substantial amounts of 
testosterone and that the enzymes of the well established pathway involv­
ing 17-hydroxyprogesterone and androstenedione are present (David _et _al., 
1965: French _et , 1965).
Development of the features of testicular feminization in the pre­
sence of a substantial production of testosterone as well as estradiol 
173 might result from one of the following mechanisms:
1) Formation of an androgen inhibitor (Neher e^ _al., 1965)
2) Peripheral conversion of androgens to estrogens (French _et al, 
3965).
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3) Other disorders of androgen metabolism (David et al., 1965; 
Rivarola ̂  a^., 1967).
4) An end organ refractoriness to androgens (Morris and Mahesh, 
1963).
Recent studies have demonstrated that estrogens can inhibit the effects 
of androgens (Hoskins and Koch, 1959; Lauritzen, 1964). The inhibition 
is seldom complete, however, and can be only accom.plished by doses which 
greatly exceed physiological levels. If there was a defect in catabol­
ism of estradiol-17S that blocked its conversion to less active compounds, 
then a large quantity would be available to inhibit the effects of test­
osterone. Although plasma estradiol-173 is elevated in pseudohermaphro­
dites, the proportion of plasma estrogen to testosterone is still less 
than that in females, who develop pubic and axillary hair in response to 
androgens. Hence, it seems unlikely that lack of virilization can be 
explained on the basis of androgen inhibition by estrogen. Furthermore, 
an androgen inhibitor would necessarily have to originate outside the 
testes, since patients with feminizing testes do not respond to treatment 
with testosterone even after removal of the gonads. A large peripheral 
conversion of testosterone to estrogen can be excluded both by failure 
to recover labeled estrogen in the urine following administration of
labeled testosterone and by the absence of increase in either plasma 
or urinary estrogens during the course of treatment with testosterone 
(French _et_ , 1965). Another possibility which can be ruled out is a 
block in the conversion of dehydroepiandrosterone to androstenedione, in­
volving the enzyme 3S-hydroxysteroid dehydrogenase. This possibility 
seemed nrobable since dehvdroeniandrosterone is elevated in the nseudo-
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hermaphrodite. However, the finding of testosterone levels in the 
human pseudohermaphrodite in the normal male range excludes this possibil­
ity (Gwinup et al., 1966; Deshpande _et aJ., 1965; Horton, Shinsako and 
Forsham, 1965; Kase and Morris, 1965; Pion _et al_. , 1965; Rosner et al., 
1965; Sharma, Dorfman and Southren, 1965; Simmer, Pion and Dignam, 1965; 
Southren et al., 1965.
A final possibility which must be considered is an alteration of 
the target site, making the peripheral organs refractory to the effects of 
testosterone. This mechanism is suggested by the observation that test­
osterone blood levels are equivalent to those of normal males, and the 
observation that these patients fail to virilize when given massive doses 
of testosterone (Morris and Mahesh, 1963).
Working Hypothesis: Supporting Evidence
for Methodological Approach
The information given in the previous sections has laid the ground­
work for the formulation of a working hypothesis originally set forth be­
fore the work undertaken in this dissertation was begun. The working hy­
pothesis is as follows:
The cause of adrenal enlargement and hyperfunction of the 
adrenal androgen biosynthetic pathway in the male pseudo­
hermaphrodite rat is due to a tropic stimulation of the 
adrenal cortex by an elevated titer of pituitary gonadotropic 
hormones.
It is to be noted that the above postulate excludes the pituitary hormone, 
adrenocorticotropin (ACTH), as the tropic factor responsible for pro­
ducing the adrenal enlargement in the male pseudohermaphrodite rat. The 
rationale for the working hypothesis is based on a number of observations 
previously noted. Paramount among these observations are the enlarged
20
pituitary and adrenal glands of the male pseudohermaphrodite rat. Hence, 
the objective of this dissertation is directed towards elucidating the 
cause or causes of enlargement of these organs. Implicit in this object­
ive is a thorough study of the endocrine status of the pituitary and ad­
renals in these animals.
The enlarged adrenal glands were construed to result from an in­
creased metabolic activity of the adrenal cortex. According to a widely 
accepted view, the pituitary hormone, adrenocorticotropin (ACTH), is the 
sole pituitary factor which can mediate such an increased metabolic act­
ivity of the adrenal cortex. A disparity in the above observation and 
this accepted view soon became apparent when it was noted that the pseudo­
hermaphrodite rats seemed to be as healthy as their littermate siblings. 
Adrenal hypertrophy and hyperplasia are generally associated with path­
ology of the Cushingoid type, due to an increased output of glucocorti­
coids which results in protein catabolism, gluconeogenesis and gastro­
intestinal pathology. In other words, if adrenal enlargement was due to 
an increased secretion of ACTH from the pituitary gland, one would expect 
to find an increased titer of glucocorticoids and possibly some concom­
itant pathology. Since these animals were asymptomatic of Cushingoid 
pathology, doubt was cast on the idea that adrenal enlargement was med­
iated via ACTH.
An additional finding which led to the formulation of the working 
hypothesis was the demonstration of a markedly elevated titer of andro­
gens in the pseudohermaphrodite rats (Stanley, Gumbreck and Easley, 1967). 
Again, if adrenal enlargement was related to an increased adrenal output 
of androgens, current concepts would suggest mediation by ACTH. This
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being crue, there would then have to be a concomitant increase in the 
glucocorticoids at least of the magnitude as that seen in the sex steroids. 
Such an increase would surely lead to a pathological state.
The last finding which led to the establishment of the working 
hypothesis was the demonstration that the pseudohermaphrodite pituitary 
had an FSH content of only 20 per cent of that of normal male controls 
(Easley, 1966), In association with the low pituitary FSH content, the 
interstitial cells (Leydig cells) of the pseudohermaphrodite testes show­
ed some hyperplasia. This finding indicated an increased output of gonad­
otropins, resulting in an increased stimulation of the interstitial cells.
The working hypothesis seemed to be consistent with the findings 
of adrenal and pituitary enlargement, absence of Cushingoid pathology, 
elevated androgen titer and indications of an increased gonadotropin out­
put. However, before accepting the working hypothesis, an experimental 
design was constructed to test the validity of the hypothesis. Included 
in the design are the following four conditions:
1) Gonadotropin titers must be greater than that of male and 
female controls-
2) 17-ketosteroid production from the adrenal glands must be 
greater than that of male and female controls.
3) Corticosterone production must be in the normal range of 
male or female control values.
4) Supression of gonadotropin output must depress adrenal 17- 
ketosteroid production without affecting the corticosterone 
values.
The rationale for these conditions is based upon the concomitant 
effects one would expect to find from an elevated gonadotropin titer, if
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indeed the gonadotropins are capable of acting as a tropic factor on the 
adrenal cortex. The gonadotropins (primarily LH) are known to induce 
steroidogenesis of androgens in the testes. Since the biosynthetic path­
way in the adrenal glands is the same as that occurring in the gonads 
for the sex steroids, it does not seem unreasonable that gonadotropins 
could stimulate the production of androgens in the adrenal glands. On 
the other hand, stimulation of the adrenal corticosteroid pathway by the 
gonadotropins is not expected. Hence, corticosterone values should be 
within the normal range of control animals. Finally, suppression of gona­
dotropin output should decrease the adrenal production of androgens with­
out affecting the corticosteroid values, if the gonadotropins are the 
tropic factors involved. Failure to confirm any of the stated conditions 
would negate the validity of the hypothesis.
Because the basic postulate of this dissertation differs to some 
extent from the current concepts of adrenal function, these concepts are 
reviewed here. A view that came into wide acceptance during the 19A0's 
held that the pituitary hormone, adrenocorticotropin (ACTH), was the 
only pituitary factor involved in maintenance of adrenal cortical function 
(Sayers and Sayers, 1948). Implied in this view was the assumption that 
there exist only one hormonal secretory zone, the zona fasciculata or 
middle cortical zone. This postulate supported the cell migration theory, 
which accordingly, assigned a germinative role to the zona glomerulosa 
(outer zone), secretory role to the zona fasciculata (middle zone) and 
considered the zona reticularis (inner zone) an area of cell decay (Deane 
and Creep, 1946; Jones, 1948), In more recent times, facts have accumulat­
ed which challenge this scheme. Deane and Creep were the early protagonists
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who favored a theory suggesting that the zona glomerulosa secretes a hor­
mone of the deoxycorticosterone type concerned primarily with electrolyte 
metabolism, while that of the zona fasciculata produced steroids dealing 
with carbohydrate and protein metabolism. The zonal theory of adrenal 
function, as it is known today, was based on the observation that after 
hypophysectomy the zona fasciculata atrophied. On the other hand, the 
zona glomerulosa was not altered markedly after hypophysectomy (Dean and 
Creep, 1946). Tying together morphology and function, the zona glomer­
ulosa exists independently in animals with adequate salt intake, while 
the zona fasciculata degenerates in hypophysectomized animals. Hence, it 
is a logical conclusion that the zona glomerulosa is connected with salt 
metabolism, involving the deoxycorticosterone type of steroids, while the 
zona fasciculata is the site of production of the glucocorticoid type of 
steroids concerned with carbohydrate and protein metabolism. Furthermore, 
according to the zonal theory, the functions of the zona fasciculata are 
directly under the control of ACTH while the zona glomerulosa is largely 
independent of pituitary control.
Creep and Deane (1947) studied the effects of the salt retaining 
steroid, deoxycorticosterone acetate, on the adrenal cortex in an attempt 
to define the function of the zona glomerulosa. They found that this 
steroid produced a zona glomerulosa lacking in sudanophils, Schiff- 
positive substances, and in biréfringent and autofluorescent materials. 
These changes were in accord with the idea that the zona glomerulosa was 
no longer secreting a hormone for which deoxycorticosterone acetate would 
serve as a substitute and that they were due to atrophy of disuse. Going 
one step further, Deane and Creep (1948) altered the ratio of sodium and 
potassium by giving diets deficient in sodium or potassium. Sodium
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depletion produced a zona glomerulosa much thicker than normal, while 
potassium depletion produced a zone reduced in thickness. Likewise, 
administration of potassium chloride caused hypertrophy of the zona glo­
merulosa. These changes were interpreted to mean that depression of the 
sodium-potassium ratio caused increased secretion by the cells of the zona 
glomerulosa. Conversely, elevation of the sodium-potassium ratio pro­
duced changes in the zona glomerulosa indicative of inactivity. Further 
support was added to the zonal theory of adrenal function when it was 
demonstrated that ACTH administration did not cause salt retention in 
the rat (Ingle, Li and Evans, 1946; Ingle et al., 1947; Bergner and Deane, 
1948). Also, on the basis of histochemical changes, the zona fasciculata 
showed evidence of increased activity after ACTH administration while the 
zona glomerulosa remained unchanged (Bergner and Deane, 1948).
■ ' The concept of adrenal cortical physiology as it has been develop­
ed above indicated two secretory adrenal zones and two types of hormones. 
An extension of this theory will be considered which involves the very 
basis of this dissertation. Androgens are produced by the adrenal cortex 
and the zona reticularis has been designated to be the site of secretion 
(Reifenstein e^ al., 1945; Albright, 1947), Implicit in this extension 
is the possibility that some other pituitary hormone besides ACTH has a 
direct influence on the adrenal cortex. In this regard, the mouse adrenal 
is of special interest because it possesses a characteristic juxtamedul- 
lary zone which shows variations with age and sex and which has been 
thought to be the androgenic layer (Howard-Miller, 1927; Grallman, 1936; 
Waring, 1935).
Mice possessing a juxtamedullary x-zone, fall into three classes:
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male mice before puberty, prepuberally castrated male mice and female 
mice. Jones (1948a; 1948b) reported that when mice in these categories 
were hypophysectomized, the x-zone disappeared. However, ACTH adminis­
tration to hypophysectomized mice caused the zona fasciculata to assume 
the appearance of a normal adrenal, while the x-zone was unaffected. In 
addition, Jones found that administration of a pituitary gonadotropin 
extract, principally LH in nature, maintained the x-zone but did not 
affect the zona fasciculata. To what extent pituitary LH influences 
the adrenals of other species is not known, but it is interesting to 
note that in the ground squirrel the adrenal cortex hypertrophies during 
the breeding season and this can be duplicated in the non-breeding period 
by giving pituitary gonadotropins (Moore _e£ a]̂. , 1934; Zalesky, 1934; 
Zalesky, Overholser and Gomez., 1941). It is of particular interest 




Management of Experimental Animals 
Male pseudohermaphrodite rats were obtained from a colony of King 
X Holtzman hybrids established in 1959 by Stanley and Gumbreck. Large 
numbers of these animals were produced by breeding females who carried 
the gene for pseudohermaphroditism. Since the anomaly was transmitted 
as a sex-linked recessive gene, statistically one-half of the males in 
any sibship were affected. Experimental animals were housed in the ani­
mal quarters at the University of Oklahoma Medical Center. Litters were 
weaned at 30 days of age and placed on Purina laboratory chow consisting 
of 23% protein, 4.5% fat, 6% fiber and 9% ash. Unless otherwise speci­
fied, animals employed in experiments were between 5 and 6 months of age. 
Male and female control rats were littermates of male pseudohermaphrodites, 
ll/hen females were employed as control animals, only virgins were selected. 
Experimental and control animals were comparable in age and within group 
variation in body weight was held to a minimum by selecting animals with­
in a 25 gram weight range.
Urine for steroid determinations was collected by placing experi­
mental and control rats in metabolic cages equipped for this purpose.
Urine was collected twice daily at 12 hour intervals, the volume measured 
in a graduate cylinder and pooled into 24 hour specimens. Several drops
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of hydrochloric acid were placed in the collection bottles to decrease 
bacterial growth, and pooled Ik hour collections were stored in a freez­
ing unit. Metabolic cages were cleaned thoroughly each day and resupplied 
with water and laboratory chow.
Assay of the Luteinizing Homone 
The principle utilized in the assay of the luteinizing hormone 
(LH) depends on the ability of LH to specifically deplete the ovary of as­
corbic acid. The degree of depletion is proportional to the dose of LH 
employed. A sample containing an unknown amount of LH was compared at 
several dosÂ ge levels with an XIH-LH-S^^ reference standard. From the 
regression lines so obtained, the potency of the unknown was computed in 
terms of the reference standard.
Preparation of Assay Animals 
Animals used for the bioassay of LH were females of the Holtzman 
strain. They were shipped from. Madison, Wisconsin at 21. days of age and 
at 25 days of age they were prepared for bioassay with a single subcu­
taneous injection of pregnant mare serum (PMS, 50 I.U.). The PMS injec­
tion was followed 60 hours later by a single subcutaneous injection of 
human chorionic gonadotropin (KCG, 25 I.U.). As a result of this treat­
ment the animals became pseudopregnant. They were used for bioassay 
during the period from 6 to 8 full days following the administration of 
HCG. At the time of use the ovaries were heavily luteinized and weighed 
consistently more than 100 milligrams each. Ovaries weighing less than 
70 milligrams were discarded, since thev sometimes vielced erratic results.
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Bioassay Procedure 
At the time of assay the animals were lightly anesthetized in an 
ether jar. The material to be tested was dissolved in 0.25 ml of saline 
and then injected intravenously via a dorsal tail vein, using a 27 gauge, 
half-inch needle. Application of ethanol (70%) to the tail helped to 
visualize the vein. All injections of pituitary extracts were made uni­
formly over a period of 10 to 15 seconds. All injections of plasma were 
made uniformly over a period of 75 seconds. Four hours after the intra­
venous injection, each animal was sacrificed by cervical fracture and the 
left ovary was dissected free and removed. The ovary was rapidly freed 
of surrounding fat on a moistened filter paper and briefly rolled on 
dry filter paper to remove adherent blood and moisture. The ovary was 
then quickly weighed on a Roller-Smith torsion balance to the nearest
0.2 mg and transferred to a ground-glass homogenizer where it was vigor­
ously homogenized. Ten milliliters of 2.5% metaphosphoric acid was 
added to the homogenate, thoroughly mixed with the homogenate, and fil­
tered through I-Jhatman #40 filter paper. The filtration process removed 
all remnants of cell membranes. The clear metaphosphoric acid filtrates 
were then analyzed for ascorbic acid by the method of Mindlin and Butler 
(1938), as modified by Parlow (1961).
Each assay included 2 doses of a reference preparation, NIH-LH- 
S,^, in addition to the same number of doses of the unknown (pituitary 
extract or plasma) and a control group which received only 0.9% saline.
Ten assay animals were used for each dosage level. Consequently, a usual 
assay employed a total of 50 animals- A total of 12 assays were carried 
out on pituitary extracts and plasma obtained from male, female and male
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pseudohermaphrodice rats ranging from 5 to 6 months of age. Plasma was
separated from blood obtained by aortic puncture. For the pituitary
assays, the pituitary powder was homogenized in 0.9% saline and allowed 
to extract for 4 hours at 4°C. All doses of the pituitary extract were 
administered in 0.25 ml of 0.9% saline.
Estimates of potency of the pituitary extracts and plasma were ex­
pressed in terms of NIH-LH-Sj^ reference standard. Values for the slope 
and standard deviation of the dose-response curves were calculated accord­
ing to the method of Finney (1964). For purposes of statistical treat­
ment, individual sample results were recorded as milligrams of ascorbic 
acid per 100 milligrams of ovarian weight and then converted to per cent 
depletion of ovarian ascorbic acid.
Chemical Determination of Ascorbic Acid 
Ascorbic acid by virtue of its redox properties has the ability to 
reduce certain colored dyes to the colorless form. According to the 
method of Mindlin and Butler (1938), a solution of ascorbic acid was 
added to a buffered solution of the dye, 2, 6-dichlorophenol indophenol, 
and the degree of decoloration, which was proportional to the concentra­
tion of ascorbic acid, was observed by means of a spectrophotometer.
Reagents and Standards
1. Metaphosphoric acid solution
a. 5% solution: one liter of distilled water was added to
50 gm metaphosphoric acid (A.R. grade) and allowed to dissolve by stand­
ing in the cold. The metaphosphoric acid solution was stored at refriger­
ator temperature and prepared fresh every two weeks.
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b. 2.5% solution: prepared fresh daily by dilution of a
5% solution with an equal volume of distilled water.
2. Ascorbic acid standards
a. Stock solution, 1.0 mg/ml: 100 mg of U.S.P. Reference
Standard Ascorbic Acid were dissolved and made to 100 ml volume with 2.5% 
metaphosphoric acid. The stock solution was stored in a freezer.
b. Concentrated standard solution. 0.10 mg/ml: the stock
solution was diluted 1:10. A sufficiently large quantity of concentrated 
standard solution was prepared to be used for the entire series of assays 
and was stored in a freezer in a number of small vials. Each vial was 
ample for the preparation of dilute standard solutions for one series of 
analyses.
c. Dilute standard solutions
Concentrated 2.5 per cent metaphosphoric
Concentration Standard Solution acid used for dilution_____
Ug ml ml
1. 2.0 0.5 25.0
2. 4.0 1.0 25.0
3. 6.0 1.5 25.0
4. 8.0 2.0 25.0
3. 2, 6-dichloropheno] indophenol solution: 20.0 mg of 2, 6-
dichlorophenol indophenol were dissolved in 100 ml distilled water at 85" 
to 95°C, and then diluted to 500 ml with distilled water. The solution 
was stored in the cold and was prepared fresh every two weeks.
4. Sodium acetate solution: 22.65 gm of sodium acetate were dis­
solved in 500 ml distilled water and the pH was adjusted to 7.0 by the 




The following description is based on the use of a Beckman DB-G 
spectrophotometer: 5 ml of indophenol-acetate solution were pipetted
into each of a series of quartz colorimeter tubes. Distilled water was 
added to a second tube. Reading at 515 mp in the DB-G, the distilled 
water blank was placed in the split beam and adjusted to read 100% trans­
mittance. A process blank was prepared by adding 5 ml of metaphosphoric 
acid to 5 ml of indophenol-acetate solution. The time of addition was 
noted, the metaphosphoric acid added rapidly, and the tube was immedi­
ately inserted into the colorimeter so that the galvanometer reading was 
observed not less than 20 seconds, and not more than 45 seconds after 
addition of the acid solution. Ascorbic acid dilute standard solutions 
containing 2.0, 4.0, 6.0, and 8.0 pg/ml, respectively, and filtered ovar­
ian gland extracts were treated in the same manner as the blank.
The galvanometer readings of the standards and blank plotted 
against ascorbic acid concentration on semi-logarithmic paper resulted 
in a straight-line curve, and from this calibration curve the ascorbic 
acid concentrations of the ovarian gland extracts were calculated. The 
total amount of ascorbic acid in the glands was obtained by multiplying 
the value taken from the standard curve by the total volume of meta­
phosphoric acid solution in the homogenate.
Assay of Plasma Follicle-Stimulating Hormone 
The technique of parabiosis was employed for the assay of plasma 
FSH. In this method a female assay animal is surgically united to an 
experimental animal (male pseudohermaphrodite rat). This procedure leads
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to an anastomosis of the two circulatory systems thus producing an ex­
change of blood. Consequently, any FSH not metabolized by the experiment­
al animal will cross over to the assay animal via the united circulation 
and stimulate ovarian enlargement. Hence, the endpoint of the assay is 
the increase in ovarian weight of the female parabiont. This method in­
dicates only an elevated titer of FSH, since normal titers are readily 
metabolized by the experimental animal.
Assay Procedure
Animals used for bioassay of plasma FSH were female littermates 
of male pseudohermaphrodite rats. Thus, the probability of an immune re­
sponse between experimental and assay animals was markedly reduced. At 
the time of surgical union, both experimental and assay rats were 30 to 
33 days of age and weighed 80 to 90 grams. The animals were anesthetized 
in an ether jar and the hair was clipped over the dorsal and lateral, body 
regions. After scrubbing the exposed areas with zephirin an oblique 
skin incision was made in the animals to be united extending from the 
gluteal region anteriorly to a midline point at the base of the skull. 
Likewise, an incision was made in the abdominal musculature, latissimus 
dorsi and trapezius muscles following the course of the skin incision.
Next, the scapuli of the two animals were united with several silk sutures 
followed by surgical union of corresponding edges of the muscle incisions 
with absorbable surgical sutures. Edges of the skin incision were united 
with noncorrosive nickel-silver wound clips. The angulation of the skin 
incision resulted in an oblique angle between the heads of the parabiotics 
and prevented any biting that might otherwise have occurred.
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The animals remained in surgical union for 15 days at which time 
they were sacrificed. The ovaries of the female assay parabiont were 
dissected free and weighed on a Roller-Smith torsion balance. The per cent 
increase in ovarian weight of the assay animals from male pseudohermaphro­
dite X female pairs were compared with those of male x female pairs. Also, 
pseudohermaphrodites were castrated and united to female assay animals in 
order to determine if the pituitary under this condition would increase 
the secretory output of FSH.
Determination of 17-Deoxycorticosteroids
The determination of the total 17-deoxycorticosteroids (unsubsti­
tuted at included the 21 hydroxypregnan-20-ones and pregnane-20: 21-
diols. The chemical procedure was carried out according to the method of 
Exley and co-workers (1961). The principle involved in this determination 
is based on the oxidation of the 2̂q.2i constituent of the 17-deoxycorti- 
coid molecule to a C2Q aldehyde. The Angeli-Rimini colorimetric reaction 
is then used for the detection of the aldehyde. Only aldehydes lacking 
substituents interacting with the aldehyde group, such as an hydroxyl 
group at position C^y, will give the colorimetric reaction. The aldehydes 
are treated with benzenesulphohydroxamic acid in a weakly alkaline solu­
tion. The hydroxamic acids formed are then detected in the reaction mix­
ture by conversion into their purple ferric complexes. Since in the pro­
cess of oxidizing the constituent to an aldehyde, the C20.21 ketols
are oxidized to etiocholanic acids, the total steroid extract is first 
subjected to a reduction process. This process reduces the C2 Q.22 ketols 
to C20-21 glycols which are then oxidized to C20 aldehydes.
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Reagents and Standards
1) Ethylene dichloride; spectroanalyzed
2) Tertiary butanol; A.S.C.
3) Methylene dichloride; spectroanalyzed
4) Ethyl acetate; spectroanalyzed
5) Petroleum ether; boiling point 36° to 45°C
6) Anhydrous sodium sulphate; granular
7) Sodium bismuthate; A.S.C.
8) Hydrochloric acid; 5N solution: 100 ml of 12 N HCL were
diluted to 5N by the addition of 140 ml of distilled water.
9) Sodium hydroxide; 3N solution: 500 ml of distiJled water
were added to 60 gm of sodium hydroxide pellets and allowed
to dissolve by standing in a cold water bath.
10) Perchloric acid; 2.5 X solution: 100 ml of 7N perchloric
acid were diluted to 2.5 N by the addition of 180 ml of 
distilled water.
11) Glacial acetic acid; 40% v/v: 40 ml of concentrated acetic
acid were diluted to a 40% solution by the addition of 60 
ml of distilled water.
12) Alkaline aqueous tertiary butanol solution: 0.125 N sodium
hydroxide and 50% aqueous tertiary butanol were mixed in 
equal volumes.
13) Potassium borohydride; 20% w/v: an aqueous solution of
potassium borohydride was made fresh each time it was used 
by dissolving 0.5 gm of the reagent in 2.5 ml of distilled 
water.
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washed successively with water (10 ml), 3N-NaOH (10 ml; shaken for 5 min­
utes) and water (2 x 10 ml). The washed extract was filtered through a 
column of anhydrous sodium sulphate and a 30 ml portion evaporated to dry­
ness .
Conversion of 17-Deoxycorticosteroids to Aldehydes 
The sample containing the residue of the ethylene dichloride ex­
tract was dissolved in tertiary butanol (0.2 ml) and treated with a fresh­
ly prepared aqueous solution of potassium borohydride (0.1 ml; 20%, w/v), 
overnight at room temperature. This procedure reduced the C20;21 ketol 
constituent. On the following morning aqueous acetic acid (3 ml; 40%, 
v/v) and sodium bismuthate (0.5 gm) were added, the mixture shaken for 10 
minutes and then centrifuged at 4,000 r.p.m. in a Universal refrigerated 
centrifuge. This procedure disrupted the C20;21 glycol bond which result­
ed in the formation of a C20 aldehyde. A portion of the supernatant 
(2.5 ml) was treated with aqueous sodium metabisulphite (0.05 ml; 20%, w/v) 
and with hydrochloric acid (1 ml; 5N) and then shaken with methylene 
dichloride (3 ml) for 15 minutes. The aqueous phase was removed and the 
extract (lower phase) washed successively with water (1 ml), 3 N-NaOK 
(1 ml; shaken for 5 minutes) and water ( 2 x 1  ml). The washed extract 
was then filtered through a column of anhydrous sodium sulphate and a 
portion (2 ml) evaporated to dryness, care being taken not to overheat 
the residue.
Determination of C20 Aldehydes 
The sample containing the aldehyde was dissolved in tertiary 
butanol (0.2 ml), treated with a freshly prepared solution of benezene- 
sulphohydroxamic acid (0.1 ml; 0.125 N) in aqueous tertiary butanol
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(50%, v/v). After 30 minutes at room temperature, water (0.5 ml) was 
added and after a further 15 minute period the mixture was shaken with 
ethyl acetate (2 ml) for 15 minutes and then centrifuged at 4,000 r.p.m. 
for 5 minutes. A portion of the top layer (2 ml) was carefully removed 
and shaken for 5 minutes with a solution (0.1 ml) of ferric nitrate 
(0.5 N) in perchloric acid (2.5N). Petroleum ether was added (2 ml) 
and the mixture shaken again. It was then centrifuged at 4,000 r.p.m., 
the organic phase carefully removed and the aqueous phase washed with a 
mixture of ethyl acetate and petroleum ether (2 m]; 1:2, v/v). The ex­
tinction of the aqueous phase was determined at 440 mu, 510 mu and 580 mu 
against a process blank obtained by submitting tertiary butanol (0.2 ml) 
alone to the treatment. Urinary blanks were also determined to account 
for colored impurities. This involved treating the ethyl acetate extract 
with perchloric acid only.
The transmittance readings at the various wavelengths were carried 
out in a Zeiss spectrophotometer, employing the microcell unit. A cali­
bration curve was constructed from aldehydes prepared from a pure cortico­
sterone reference standard. Eight graded concentrations of the reference 
standard were employed in each determination. The galvanometer readings 
were plotted on semi-logarithmic paper against the various concentrations 
of the reference standard. From the calibration curve so constructed, the 
value of the unknown was calculated.
Determination of Total Neutral 17-Ketosteroids 
The majority of colorimetric methods for the determination of the 
total neutral 17-ketosteroids depend for their final determination on 
the reaction originally described by Zimmermann (1935). This reaction relies
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on [he fact chat steroids containing the group -COCH2- will give a purple 
color when treated with m-dinitrobenzene in the presence of alkali. The 
literature contains information on a large number of methods for the esti­
mation of total urinary 17-ketosteroids in which the final determination 
is made colorimetrically using the Zimmermann (1935) reaction. These me­
thods have been reviewed by Loraine (1958) and Dorfman (1962). The 
method employed in the present work was a modification of the procedure 
devised by Drekter et_ a]̂ ., (1952) for the determination of total neutral 
urinary 17-ketosteroids. The modification involved the substitution of 
carbon tetrachloride for ethylene dichloride because experience with the 
latter indicated that excessive contaminating chromogens were extracted 
and alcoholic potassium hydroxide was substituted for aqueous potassium 
hydroxide. Furthermore, filtration through anhydrous sodium sulphate was 
added as an additional step. Otherwise, the procedure was carried out 
as originally described by Drekter and co-workers, but employed larger 
volumes of urine and solvent.
Reagents and standards
1) Hydrochloric acid; A.C.S.
2) Carbon tetrachloride; spectroanalyzed.
3) Absolute ethanol; U.S.I.
4) Anhydrous sodium sulphate.
5) Sodium hydroxide; 10% solution: 500 ml of distilled water
were added to 50 gm of sodium hydroxide pellets and allowed 
to dissolve by standing in a cold water bath.
6) Potassium hydroxide; 2.5 M alcoholic solution: The alcoholic
KOH solution was made fresh -each time it was used by grinding
39
7.0 gm KOH in 25 ml of 100% ethanol, filtering the 
supernatant fluid to remove insoluable carbonate and 
adding another 25 ml portion of alcohol to the residue 
which was ground again and filtered. This grinding was 
done with a glass rod in a 50 ml graduate cylinder set 
in ice water.
7) M-dinitrobenzene; 2% solution: m-dinitrobenzene solution was
made by placing 1 gm of the reagent in a 50 ml volumetric 
flask and filling to the mark with 100% ethanol. The flask 
was warmed slightly to facilitate dissolution.
8) Dehydroepiandrosterone reference standard; 50-500 yg/ml:
a graded series of concentrations of this steroid were 
made by dissolving 50 mg of dehydroepiandrosterone in 100 ml 
of 100% ethanol and diluting to the appropriate concentra­
tion with additional 100% ethanol.
Acid Hydrolysis and Steroid Extraction 
A pooled 24 hour urine specimen (250 ml) was placed in a round- 
bottom flask (500 ml capacity) and to this were added 25 ml of concentrat­
ed hydrochloric acid. A reflux condenser equipped with a water jacket 
was attached to the flask which was then heated on a hot plate for 10 
minutes. This procedure removed the glucuronate and sulphate moitiés 
conjugated to the 17-ketosteroids and rendered them soluble in an organic 
medium. The flask containing the hydrolyzed urine was rapidly cooled and 
80 ml of carbon tetrachloride added and permitted to reflux in a boiling 
water bath for 20 minutes. The flask was again cooled and the aqueous 
layer removed in a separatory funnel. The organic extract was filtered
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through IVhatman #40 filter paper in a Buchner funnel with suction and 
washed twice with 20 ml of water. The carbon tetrachloride extract was 
shaken with solid sodium hydroxide pellets followed by a wash with 10% 
aqueous sodium hydroxide (2 x 20 ml) and again subjected to a water wash 
(2 X 20 ml). This procedure removed interfering chromogens and the acidic 
and phenolic fractions. The washed extract was filtered through a column 
of anhydrous sodium sulphate and evaporated to a residue.
Analytical Procedure
For the colorimetric determination a series of 50 ml test tubes 
were prepared as follows:
1) Reference standard solutions: from a solution containing
500 tg/ml of dehydroepiandrosterone (U.S.P.), a graded series of con­
centrations ranging from 50 to 500 yg were prepared by diluting with an 
appropriate amount of 100% ethanol. To each test tube in the series was 
pipetted 1 ml of the appropriate concentration.
2) Unknown urine extract: 1 ml of the urine extract.
3) Unknown urine extract blank: 1 ml of urine extract plus 1
ml of 100% ethanol.
4) Process blank; 1 ml of 100% ethanol.
One milliliter of 2.5 M KOH in 100% ethanol was pipetted into every tube,
and to each tube, except the one containing the unknown urine extract
blank, 1 ml of 2% m-dinitrobenzene in 100% ethanol was added. The tubes 
were set in a dark place at about 25°C and left for 45 minutes. They 
were occasionally shaken to facilitate the color development. After 
color development, 25 ml of 70% ethanol was added to each tube and the 
contents mixed by inversion. The extinction of the reference standards
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and unknown was determined at 440 mp, 510 my and 580 my against the pro­
cess blank. A calibration curve was constructed from a pure dehydroepi- 
androsterone reference standard. Six graded concentrations of the refer­
ence standard were used to construct the calibration curve in each deter­
mination. The galvanometer readings were plotted on semi-logarithmic 
paper against the various concentrations of the reference standard. From 
the calibration curve, the value of the unknown was calculated.
Method of Histological Preparation
Histological sections were prepared to investigate the possibility 
of a correlation between the high titer of gonadotropins, the high adrenal 
androgen output and the zonation of the adrenal gland, and to define histo­
logically the region of cortical hyperplasia.
Reagents and Stains
]) Absolute ethanol; U.S.I.
2) Xylol; AP
3) Albumin
4) Watterman paraffin; melting point 52°C
5) Bouin fixative: 1 gm of Picric acid crystals were dissolved
in 75 ml of warm distilled water. The volume was brought 
to 105 ml by the addition of 25 ml of formalin and 5 ml of 
acetic acid.
6) Neutral buffered formalin; 4 gm of monosodium phosphate and
6,5 gm of disodium phosphate were dissolved in 900 ml of 
distilled water. The solution was brought to a volume of 
one liter by adding 100 ml of formalin.
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7) Delafield's hematoxylin; 1 gm of hematoxylin dissolved in
10 ml of absolute ethanol was added to a saturated aqueous 
solution of ammonia alum. This mixture was exposed to air 
and light for 6 to 8 weeks, filtered and 25 ml of methanol 
and glycerin added.
8) Eosin counter stain; 0.5 gm of eosin crystals were dissolved
in 100 ml of 95% ethanol.
9) Mounting medium: 50 gm of acacia were dissolved in 100 ml
of distilled water at 55°C and to this was added 100 gm 
of thymol as a preservative.
Method of Embedding and Staining
Following fixation with Bouin's fixative or buffered formalin, the 
tissues were rinsed in tap water for 5 minutes and subjected to a dehydra­
tion process, using graded concentrations of ethanol. The dehydration 
process consisted of one rinse in 35%, 50% and 70% ethanol followed by 
8 hours in 80% and 95% ethanol respectively. The final dehydration step 
involved several changes of absolute ethanol over a period of one hour. 
Embedding was accomplished by clearing the tissues in xylol for 2 hours 
followed by infiltration in 1/2 xylol - 1/2 paraffin for 4 hours. The 
tissues were transferred into melted paraffin and embedded in paper boxes.
Tissue blocks were mounted on a microtome and sectioned at 5u.
The sectioned ribbons were affixed to a glass slide smeared with albumin 
and water, and heated slightly to insure the removal of any wrinkles in 
the ribbon.
After rehydration the slides were placed in hematoxylin for two 
minutes and then rinsed in tan water for 15 minutes. The sections were
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counter-stained with eosin for 30 seconds and again dehydrated by a grad­
ed series of ethanol solutions. After clearing in xylol for 15 minutes 




For convenience of interpretation, data appearing in this section 
are presented both in tabular and graphic form. Individual values plot­
ted as a mean in any graph can be found by referring to the corresponding 
table. Attention is directed to comparative values, since interpretation 
of experimental results is dependent on these comparisons.
Assay of the Luteinizing Hormone 
The first condition of the working hypothesis necessitated quanti­
tation of the gonadotropin titer in the pseudohermaphrodite rat. With 
this in view, twelve separate assays were carried out on pituitary pre­
parations and plasma from normal male, female and male pseudohermaphrodite 
rats. A total of 50 test rats were employed in each assay (10 animals 
per dose level), using two dose levels of pituitary extract or plasma 
and two dose levels of an NIH-LH reference standard, plus a saline control 
group. Data were recorded as micrograms of ascorbic acid from the ovary 
of each assay rat and converted to micrograms per 100 milligrams ovarian 
weight. Since a regression analysis was employed to compute the relative 
potency of each preparation, micrograms per 100 milligram.s ovarian weight 
were converted to per cent depletion of ascorbic acid. This gave regres­
sion lines with a positive slope, since the most potent preparation gave
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a smaller ovarian ascorbic acid content, but resulted in the larger per 
cent depletion.
The relative potency of each test preparation was determined by 
computing the slopes of the dose-response curves for test and standard 
(NIH-LH) preparations and then expressing the slopes as a ratio. Regres­
sion lines were constructed between points obtained from the average per 
cent depletion of ovarian ascorbic acid at two dose levels. The lines 
crossed the ordinate at a fixed point computed from the regression equa­
tion. Validity tests were determined from the analysis of variance for 
the assays by dividing the error mean square into deviation from regres­
sion mean square. The calculated F value so obtained was then compared 
with the tabulated F value for the appropriate degrees of freedom.
Assays showing significant deviation from regression were declared sta­
tistically invalid. Significant deviation from regression generally 
resulted from an underestimate of the unknown preparation at the low 
dose level. Since the relative potency computed from the slopes of the 
dose-response curves in non-linear assays either underestimated or over­
estimated the true relative potency, these cannot be taken as absolute 
values. However, the relative potencies in those assays showing non- 
linearity do indicate differences between experimental and control 
groups, since all data were collected and treated in the same manner.
Values of the per cent depletion of ovarian ascorbic acid from 
two separate LH assays of pseudohermaphrodite rat pituitary are listed 
in Tables 1 and 2. The average values with standard errors (Re) produced 
by 25 pg and 100 ug dose levels of pituitary extract are listed at the 
bottom of columns 1 and 2, while those resulting from 0.4 pg and 1.5 pg
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TABLE 1
ASSAY OF LH FROM PITUITARY GLANDS OF MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Pseudo Pituitary Pseudo Pituitary NIH-LH NIH-LH
25 pg 100 pg 0.4 pg 1.6 pg
Per cent Depletion of Ovarian Ascorbic Acid
30.1 50.1 24.9 39.0
34.6 46.9 31.8 39.4
16.9 38.5 31.8 26.0
39.6 43.6 31.9 39.9
19.2 41.4 26.6 37.4
9.3 41.2 26.9 41.3
9.8 41.0 24.9 25.0
9.8 31.6 28.1 40.0
9.1 42.0 23.3 38.7
11.7 38.8 24.0 38.3
Zxj_
n
19.0 ±  3.7 41.5 + 1.7 27.4 + 1.9 36.5 +1,1
Zxi2 4,823.9 17,453.2 13,443.0 7,619.8
(Zxi)2
n
3,613.8 17,230.8 13,104.4 7,518.6
bg = 12 3 bj. = 14.0 R = 113.8% R= = 17.2%
Values representing per cent depletion have been calculated from 
a Saline control treatment group.
bg - Slope of standard preparation
Slone of test preparation
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TABLE 2
ASSAY OF LH FROM PITUITARY GLANDS OF MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Pseudo Pituitary Pseudo Pituitary NIH-LH 
25 JJg 100 Pg 0.4 pg
NIH-LH
lc6 pg
per cent Depletion of Ovarian Ascorbic Acid
29.1 35.9 12.4 24.2
20.6 43.1 10.1 35.7
20.7 43.7 12.3 36.7
6.3 35.9 13.5 40.4
17.5 31.9 20.0 35.7
27.4 35.9 11.4 29.7
7.0 42.9 10.4 39.1
18.1 42.1 8.9 33.1
22.5 44.1 8.4 30.0
20.5 43.0 16.3 29.0
IXi
n
19.0 + 2.4 39.9 + 1,4 12.4 + 1.1 33.4 + 1.6
4,093.6 16,057.9 1,642.9 11,361.2
n
3,594.8 15,880.2 1,530.2 11,128.9
bg = 15. 1 bj. = 19.2 R = 131. 8% R= = 11.5%
Values representing per cent depletion have been calculated 
from Saline control treatment groups.
b - Slope of standard preparation
bj. - Slope of test preparation
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TABLE 3










1 6  ug
Per cent Depletion of Ovarian Ascorbic Acid
24.2 42.5 13.2 35.8
26.0 41.4 19.8 37.2
15.1 36.0 7.9 41.6
21.4 41.2 15.9 33.4
19.1 44.3 21.5 38.7
18.1 43.4 13.6 39.2
20.2 36.4 17.4 30.0
22.3 33.7 7.0 42.7
15.1 45.2 22.5 38.8
26.7 30.4 20.6 40.5
n
20.8 + 1.3 39.4 + 1.6 15.9 + 1. 7 37.8 + 1.2
Z%i^ 4,486.3 15,770.3 2,811.1 1̂ , 414.9
(Exi)^
n
4,334.7 15,547.3 2,540 8 280.8
bg = 16.0 b[ =17.7 B. 110.6% R. = 8.3%
Values representing per cent depletion have been calculated 
from a Saline control treatment group.
bg - Slope of standard preparation
Slope of test preparation
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TABLE 4












Per cent Depletion of Ovarian Ascorbic Acid
29.3 44.9 26.0 42.6
21.8 43.4 18.6 42.9
18.8 39.6 19.8 40.5
17.8 39.5 2 0 4 34.6
9.9 39.6 26.4 37.8
14,8 41 8 15.2 44.5
18.2 35.6 21.2 41.7
18.4 43.3 25.1 44.4
15.6 44.1 19.0 44.6
18.9 36.3 28.0 35.6
Z%i 18.4 + 2.6 40.4 + 1,1 22.0 + 1.3 40.9 2  1.2
n
3,951.4 16,447.3 4,982.6 16,854.2
(zXi)^ 3,367.2 16,329.7 4,826.8 16,728.1
n
bg = 17.5 be = 16.6 R = 94.9% Ra = 7.9%
from a
Values representing per cent depletion have been 
Saline control treatment group.
calculated
bg - Slope of standard preparation
bj. - Slope of test preparation
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Regression Lines For The Assay of The Luteinizing Hormone From
Pituitary Glands of Male Rats






Figure 2. The pituitary preparation (50 Pg and 200 Pg) was 
compared to an NIH-LH reference standard (0.4 pg and 1.6 Pg) by 
determining the slopes of the dose-response curve and expressing the 
p otency as a ratio of the determined slopes.
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TABLE 5
ASSAY OF LH FROM PITUITARY GLANDS
OF FEMAL-E RATS
Treatment Group;3
Female Pituitary Female Pituitary NIH-LH NIH-LH
50 yg 200 ug 0.4 ,,g 1.6 ug
Per cent Depletion of Ovarian Ascorbic Acid
11.9 33.7 24.1 35.1
18.3 24.1 17.5 28.6
10.9 43.6 27.6 40.2
3.5 34 5 21.2 31.0
2.2 30.7 32.7 40.1
5.4 27.4 38.6 35.8
12.5 34 4 16.8 42.8
4.6 31,6 23.0 39.6
6.9 32.9 21.1 41.6
15.4 34.0 23.0 41.3
9.2 + 1.7 32.7 + 1.6 24.6 + 2.1 37.6 + 1.5
2ZXi 1,103.7 10,921.3 6,442.9 4,352.9
(Zxi)2
"ir
839.1 10,684.4 6,031.9 14,145.1
bg = 17.7 bt = 12.6 R = 71.2% Rg = 7.7%
Values representing per cent depletion have been calculated 
from a Saline control treatment group.
bg - Slope of standard preparation 
bj. - Slope of test preparation
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TABLE 6
ASSAY OF LH FROM PITUITARY GLANDS
OF FEMALE RATS
Treatment Groups
















































Values representing per cent depletion have been calculated 
from a Saline control treatment group,
bg - Slope of standard preparation
b- - Slone of test nrenaration
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Regression Lines For The Assay Of The Luteinizing Hormone From












Figure 3. The pituitary preparation (50 ug and 200 ug) was compared 
to an FIH-LH reference standard (0.4 ug and 1.6 ug) by determining the slopes 
of the dose-response curve and expressing the potency as a ratio of the 
determined slones.
56
Relative Potency of The Luteinizing Hormone From Pituitary Glands 








0"O3 ca O c/] 
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rH  COca COz <
cu CO
OJ CO
Figure 4. The relative potencies were determined by computing 
the slopes of the regression lines for test and standard preparations 
and then expressing the slopes as a ratio. The dose levels of pituitary 
preparations of pseudohermaphrodites must be taken into consideration 
when comparisons are made with control groups, since the dose levels 
were only 1/2 of that employed for controls.
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pituitary.
Plasma samples from normal male, female and male pseudohermaphro­
dite rats employed in the LH assays caused a significant ovarian ascorbic 
acid depletion, especially at the high dose. However, the plasma assays 
all showed significant deviation from regression and therefore are con­
sidered statistically invalid. Values are shown in Tables 7 and 8 for the 
assay of pseudohermaphrodite rat plasma. Dose levels of 0.5 ml and 2.0 ml 
of plasma, and 0.4 ug and 1.6 ug of the reference standard resulted in 
relative potencies of 14.5 + 3.5% and 13.9+4.2%. In addition, the re­
gression lines illustrated in Figure 5 gave an average relative potency 
of 14.2 + 3.9%. Values for two assays of male plasma listed in Tables 9 
and 10 and Figure 6 are only slightly below those produced by pseudoher­
maphrodite plasma, but the dose levels employed for the male plasma assays 
were one-third larger. Dose levels of 0.75 ml and 3.0 ml of male plasma, 
and 0.4 ug and 1.6 ug of the reference standard produced relative poten­
cies of 12.8 +4.1% and 14.0 + 4.6%. The average relative potency for 
male rat plasma shown in Figure 6 was 13.4 + 4.4%. The relative poten­
cies of female rat plasma shown in Tables 11 and 12, and Figure 7 were 
below those of the pseudohermaphrodites as well as those of normal males. 
Figure 7 shows an average relative potency of 9.7 +4.0% for female rat 
plasma. Again, the relative potencies are only estimates of the actual 
values due to curvilinear regression lines. However, Figure 8 shows 
that the pseudohermaphrodite plasma has a relative potency at least as 
large as that of males or females at only 2/3 the dose level. These com­
parisons indicate that the relative potency of female rat plasma< male 
plasma < pseudohermaphrodite plasma.
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TABLE 7
ASSAY OF LH FROM PLASMA OF MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Pseudo Plasma Pseudo Plasma NIH-LH NIH-LH
0.5 ml 2.0 ml 0.4 ug lc6 ug
Per cent Depletion of Ovarian Ascorbic Acid
4.4 18.4 18.6 37.0
8.8 19.3 24.5 39.8
5.6 16.9 21.9 44.2
6.4 13.4 19 8 42.1
5,3 15.2 16.7 38.9
8. 6 9.1 22,9 40.5
6,9 14 7 21=6 41.6
10.3 20.9 18.4 35.6
4.9 17.3 20.8 39,9
9.0 13. 7 17,5 33.7
Z^i 7,0 + 0,64 15.9 + 1.8 20.3 i  0,79 39,3 + 1,
n ■
ZXi^ 529.8 2,629.9 4,165.2 15,558 2
(Zxi)2 492.8 2,524.9 4,108.7 15,468.5
n
bg = 19.3 bt = 2.8 R = 14.5% Rs = 3.5%
Values representing per cent depletion have been calculated 
from a Saline control treatment group.
b - Slope of standard preparation
bj. - Slope of test preparation
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TABLE 8











Per cent Depletion of Ovarian Ascorbic Acid
6 r 0 17,1 22,9 41 1
6.5 14-5 26.2 40.4
10.5 8.1 22.0 45.9
6.9 12.3 302 41.6
9.6 16.9 31,0 40-2
5.6 15.5 23,7 45.0
4.0 19.3 21.2 44.8
5.2 16.0 32.4 40.6
8.4 15.7 22.0 42.2
8.6 14.0 26.9 40 1
7,1 + 0.66 16 9 + 0,97 25.9 + 1.3 ,2.2 + 0.^1
n
547.2 2,316.4 6,836.4 17,844 0
n
508.4 2,232.0 6,682.2 17,799.9
bg = 19.5 bt = 2.7 R = 13.9% Ra = 4.2%
Values representing per cent depletion have been calculated 
from Saline control treatment group.
bg - Slope of standard preparation
bj- - Slope of test preparation
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Regression Lines For The Assay Of The Luteinizing Hormone From



















X -- NIH-LH Standard
• -- Pseudo Plasma
Potency: 14.2 + 3.9%
2.0 ml
0.' y g 1.6 ng
Dose Level
Figure 5. The plasma preparation (0.5 ml and 2.0 ml) was 
compared to an NIH-LH reference standard (0.4 ug and 1.6 yg) by deter­
mining the slopes of the dose-response curve and expressing the potency 
as a ratio of the determined slones.
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TABLE 10










Per cent Depletion of Ovarian Ascorbic Acid
11.2 20 5 17 1 33 6
10.0 16.1 23.9 40-3
6.1 18-1 19-8 46 4
7.6 9.8 22 1 4 5 7
9-7 13.0 25.5 39 5
10.5 r  3 20 7 40 6
3.1 14 7 20 0
10.0 13,4 22.9 37.9
5,1 15 6 22.1 43 8
7,9 14,3 21.1 42.0
Z^i
n
8,1+0,55 15.3 - 0-95 21, 5 + 0 79 40.5 2  1-33
722,8 2,414,9 4,686.8 16,553-9
(ixi)2
n
695.3 2,334 8 4,631.1 16,394 4
bg = 17 8 bf = 2,5 R = 14 0% Ra = 4.6%
Values representing per cent depletion have been calculated 
from a Saline control treatment group-
bg - Slope of standard preparation 
b^ - Slope of test preparation
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Regression Lines For The Assay Of The Luteinizing Hormone From










X — NIH-LH Standard 
• — Male Plasma
0.4 yg
Dose Level
Figure 6. The plasma preparation (0.75 ml and 3.0 ml) was com­
pared to an NIH-LH reference standard (0.4 yg and 1.6 yg) by determining 
the slopes of the dose-response curve and expressing the potency as a 
ratio of the determined slopes.
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TABLE 11




Female Plasma NIH-LH 
3.0 ml 0.4 ug
NIH-LH 
1.6 ug
Per cent Depletion of Ovarian Ascorbic Acid
4.4 10.6 20.4 42.4
1.6 8 5 18.6 40.8
0 17.3 24.0 45.5
0.8 11.6 19.5 39-6
1,1 15 8 21 6 41 1
7.0 12.2 17.4 40 2
0 14.4 25 6 38 6
10.2 9.6 22.2 44.4
4.7 10.1 16.6 40 5




Values representing per cent depletion have been calculated 
from a Saline control treatment group.
bg - Slope of standard preparation
bj. - Slope of test preparation
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TABLE 12










Per cent Depletion of Ovarian Ascorbic Acid
0 12.8 25, 1 38.1
0 8.. 9 18.0 42.0
1,6 11,1 22,9 43.1
9.0 15 6 18 3 35.3
3,7 14 2 15.8 44.9
0 11. 7 21.9 41, 3
1.9 14. 9 21 2 37.9
4.9 18.0 23.7 41,1
2.1 17.8 17.2 42.5
1,3 12.5 15.4 40.7
n.
2.5 + 0.89 13.8 T 0.93 20.0 + 1.1 40.7+0-90
131.0 1,967.3 4,086.7 16,629.4
(ZXi)2 60.0 1,890.6 3,980,0 16,556 8
n
bs = 19,9 b j. = 2.0 R = 10.0% Ra = 4.3%
Values representing per cent depletion have been calculated 
from a Saline control treatment group.
bg - Slope of standard preparation
bj- - Slope of test preparation
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degression Lines For The Assay Of The Luteinizing Hormone From
Plasma of Female Rats
50
'— NIH-LH Standard
30 o Female Plasma




0.4 yg 1.6 yg
Dose Level
Figure 7. The plasma preparation (0.75 ml and 3.0 ml) was com­
pared to an NIH-LH reference standard (0.4 yg and 1.6 yg) by deter­
mining the slopes of the dose-response curve and expressing the potency 
as a ratio of the determined slones.
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Relative Potency Of The Luteinizing Hormone From The Plasma Of 
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Figure 8. The relative potencies were determined by computing 
the slopes of the regression line for test and Standard Preparations and 
(_hen expressing the slopes as a ratio. ihe dose levels of plasma pre­
parations of pseudohermaphrodites must be taken into consideration'when 
comparisons are made with control groups, since the dose levels were only 
2/3 of that employed for controls.
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Assay of the Follicle-Stimulating Hormone 
To further quantitate the gonadotropin titer in male pseudoher­
maphrodite rats, forty pairs of rats were surgically united in parabio­
sis for the assay of plasma FSH. Of the 40 pairs originally united, 33 
per cent developed parabiosis intoxication and were subsequently dis­
carded. Female assay rats were surgically united at 30 to 33 days of 
age with male and pseudohermaphrodite siblings. The parabiotics were 
sacrificed 15 days following surgical union. Table 13 lists the ovarian 
weights of female assay rats 15 days after surgical union. The pseudo­
hermaphrodite X female pairs listed in Column 2 resulted in an average 
ovarian weight of 66.6 + 5.5 mg in contrast to 29.7 + 1.9 mg for male 
X female unions listed in Column 4. The increase in ovarian weights of 
female parabiotics shown in Figure 9 indicates that a significant in­
crease of plasma FSH exists in the pseudohermaphrodite rat.
In order to investigate the secretory output of FSH after cas­
tration, normal male and pseudohermaphrodite rats were castrated at the 
time of surgical union to female siblings. Columns 1 and 3 of Table 
13 lists the ovarian weights of castrate pseudohermaphrodite X female 
and castrate male X female pairs. Average ovarian weights of 101,1 + 
14.4 mg and 101.3 + 14,0 mg respectively, demonstrate that the secretory 
output of FSH increases following castration. Likewise, Figure 9 shows 
that the pituitary of the pseudohermaphrodite, after castration, further 
increases the secretory output of FSH to levels comparable to that of 
the castrate male.
Determination of Total Neutral Urinary 17-Ketosteroids 
Determinations of urinary 17-ketosteroids were undertaken to
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TABLE 13
OVARIAN RESPONSE OF FEMALE RATS IN PARABIOSIS 



















Ovarian Weight of Female Assay Rats
mg mg mg mg mg
98.0 67,4 146.0 30.0 27,4
42.0 64.6 57.0 29.5 26 0
110.0 76.4 105.0 32.4 28 2
94.0 82.0 85.4 20.0 28.6
95.0 73.0 96.6 28.0 31.0
176.0 37.0 66.0 32.0 26.4
93.0 65,5 153,0 36.0 28.0
Z^i 101.1* 66.6* 103.3* 29.7 2 7 ^
n
80,954.0 32,265.1 ^79,979.7 6,324.0 5,481.9
n
71,609.1 31,009.0 71,811.6 6,174.6 5,465.6
S X 14.4 5.5 14.0 1,9 0.62
Test and assay rats were surgically united in parabiosis at 
30-33 days of age and sacrificed 15 days subsequent to surgical union,
^Significantly different at the .01 level from normal female 
control rats.
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Ovarian Weights of Female Rats In Parabiosis With Normal And 






























Figure 9. Female Rats were surgically united in parabiosis 
with male and pseudohermaphrodite rats at 30-33 days of age and 
sacrificed 15 days subsequent to surgical union.
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quantitate the production of these steroids in the pseudohermaphrodite and 
control rats and also, to establish a baseline value from which the adren­
al contribution could be assessed under various conditions. A total of 
128 separate urinary 17-ketosteroid determinations were carried out on 
urine collections from male, female and male pseudohermaphrodite rats.
Each determination was carried out on a pooled 250 ml aliquot of a 24-hour 
urine collection and individual rat values were calculated from the value 
of the total aliquot. Since each determination was carried out on a pool­
ed urine collection, individual values actually represent an average- 
Table 14 lists the results of 30 analyses conducted on urine from normal 
male, female and pseudohermaphrodite rats with values reported in ug per 
24 hours. The average of 10 determinations each for males, females and 
pseudohermaphrodites were 18.0 + 0.71 pg, 33.6 + 0,60 pg and 105.2 + 1.3 ug 
respectively. The data summarized in Figure 10 demonstrate that the 
male pseudohermaphrodite rat has a markedly elevated output of urinary 
17-ketosteroids in comparison with those of male and female controls.
In addition, the female values are considerably above those of males-
In order to investigate the source of 17-ketosteroid production in 
pseudohermaphrodite and control rats, 30 separate determinations were 
carried out on urine from castrate males, females and pseudohermaphrodites, 
These findings are listed in Table 15. The 24-hour values dropped from 
105.2 + 1.3 pg for the normal pseudohermaphrodite to 44.7 + 1-0 pg for 
the castrate pseudohermaphrodite and from 18.0 + 0.71 pg to 13.1 +
0.62 pg for the castrate male, while the female values remained essent­
ially equivalent to the pre-castration values. Thus in the case of the 
pseudohermaphrodite, the testes accounted for more than one-half of the
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TABLE 14
DETERMINATION OF TOTAL NEUTRAL URINARY 17-KETOSTEROIDS FROM
THE URINE OF NORMAL MALE, FEMALE AND
MALE PSEUDOHERMAPHRODITE RATS
Treatment Groups
Normal Male Normal Female Normal Pseudo
24 Hour Urinary 17-Ketosteroid Values






21.3 34.0 92 4
16.9 30.0 112.0
17.8 35.2 116.0





4x^2 3,278.0 11,288.5 111,768.5
Cxi)2
n
3,232.8 11,256.0 110,628 3
Sx 0.71 0.60 1.3
Steroid determinations were carried out on pooled 24 hours urine 
collections and individual rat values were calculated from the total alicuot-
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TABLE 15
DETERMINATION OF TOTAL NEUTRAL URINARY 17-KETOSTEROIDS FROM
THE URINE OF CASTRATE MALE, FEMALE AND MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Castrate Male Castrate Female Castrate Pseudo
24 Hour Urinary 17-Ketosteroid Values -

















Sx 0.62 0.52 1.0
collect
Steroid determinations 
ions and individual rat
were carried 
values were
out on pooled 24 hour urine 
calculated from the total
aliauot.
Average Urinary 17-ketosteroid Values Of Normal And Castrate Male,
















Figure 10. The above values represent an average of 10 sep­
arate determinations. Steroid determinations were carried out on 
pooled 24 hour urine collections and individual rat values were cal­
culated from the value of the total aliquot.
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17-ketosteroid values, while in the male and female, the adrenal contri­
bution was preponderant. The data included in Figure 10 demonstrates 
that the adrenal output of 17-ketosteroids in the pseudohermaphrodite 
IS considerably above that of the male or female controls.
With baseline values established and the sites of production 
identified and quantitated, the adrenal contribution to the urinary 17- 
ketosteroids was studied under various conditions. The principle point 
of the working hypothesis considered the gonadotropic hormones to be 
tropic to the adrenal cortex; accordingly, the adrenal contribution to 
the urinary 17-ketosteroids was studied under the condition of gonado­
tropin suppression in order to evaluate this postulate. The gonadotro­
pic hormone secretion was suppressed by administering 50 ug of diethyl- 
stilbestrol per day to pseudohermaphrodite rats, and to male and female 
control rats. Table 16 lists 24-hour urinary 17-ketosteroid values from 
determinations carried out under the above conditions. In contrast to 
an average value of 44.7 -h 1.0 ug for castrates, the pseudohermaphrodite 
value fell additionally to a mean value of 32.1 + 0.52 ug, while the male 
value fell to that of the castrate condition. The female output dropped 
slightly from an average value of 33.6 + 0.60 ug to 30.0 + 0.62 ug- The 
data included in Figure 11 indicate that suppression of gonadotropic 
hormone secretion decreased not only the testicular value in the pseudo­
hermaphrodite but also the adrenal contribution.
In order to further test the effect of gonadotropin suppression, 
diethylstilbestrol was administered to castrate pseudohermaphrodite, and 
male and female control rats. The values listed in Table 17 and Figure 
11 demonstrate that the adrenal contribution to the urinary 17-ketosteroids
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TABLE 16
DETERMINATION OF TOTAL NEUTRAL URINARY 17-KETOSTEROIDS FROM 
THE URINE OF STILBESTROL AND DEXAMETHASONE TREATED 















24 Hour Urinary 17-Ketosteroid Values
^g/24 hr Mg/24 hr pg/24 hr ug/24 hr
10.8 28.6 30.0 16,6
12.3 31.3 33.3 18.3
11.8 27.0 30.8 17. 5
13.1 30.6 32. 5 20 0
10.3 29.2 33.3 15.8
12.3 31.8 30.8 17.5
10.5 30.0 33.3 16 6





11,7 30.0 32.1 17.7
ZXi? 1,382.3 9,047.3 10,314.9 2,516.8
(2x^)2
n
1,371.2 9,012.0 10,291.3 2,502.8
Sx 0.35 0.62 0.52 0.40
Steroid determinations were carried out on pooled 24 hour urine 
collections and individual rat values were calculated from the total aliquot
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table 17
DETERMINATION OF TOTAL NEUTRAL URINARY 17-KETOSTEROIDS FROM
THE URINE OF STILBESTROL TREATED CASTRATE MALE, FEMALE











Hour Urinary 17-Ketosteroid Values
,_,g/24 hr ug/24 hr pg/24 hr
13.7 29.0 29,2
16.0 32.7 30.3
10,8 30.6 31 2









2IXi 1,712.8 9,866.2 9,275.5
(zXi)2 1,690.0 9,834.5 9,259-8
n
S X 0.51 0.60 0.42
collec
Steroid determinations 
tions and individual rat
were carried out on pooled 24 hour urine 
values were calculated from the total ali-
auot.
40 J
Average Urinary 17-ketosteroid Values Of Stilbestrol And Dexa­
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Figure 11. The above values represent an average of 10 
separate determinations. Steroid determinations were carried out 
on pooled 24 hour urine collections and individual rat values were 
calculated from the value of the total aliquot.
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was depressed in the pseudohermaphrodite rat from an average castrate 
value of 44.7+1.0 pg to a value of 30.4+0.42 pg. The male and female 
control values were essentially the same as the previous castrate values. 
These results demonstrate that suppression of gonadotropic hormone sec­
retion leads to a depression of the adrenal output of 17-ketosteroids 
in the male pseudohermaphrodite rat.
In another series of experiments, ACTH titers were suppressed in 
pseudohermaphrodite and control rats by administering dexamethasone in a 
dose of 50 pg per day. This treatment completely abolished urinary 17- 
ketosteroid output in male and female control rats, and depressed values 
in the pseudohermaphrodite far below the previous testicular or adrenal 
values. These results are listed in the last column of Table 16 and in 
Figure 11. Thus, dexamethasone not only abolished the adrenal output, 
but also markedly depressed the testicular contribution.
Determination of Urinary 17-Deoxycorticosteroids 
Determinations of urinary 17-deoxycorticosteroids were undertaken 
to assess the adrenal function ofmale pseudohermaphrodite and control 
rats with respect to corticosteroid production. Each determination was 
carried out on a pooled 120 ml aliquot of a 24-hour urine collection and 
individual rat values were calculated from the value of the total aliquot. 
Table 18 lists values in pg per 24 hours of urinary 17-deoxycorticoste­
roids. The average of 9 determinations each for males, females and pseudo­
hermaphrodites were 9.2 + 12 pg, 16.0 + 0.5 pg and 16.7 + 0.31 pg res­
pectively. These figures demonstrated that the urinary corticosteroid 
output of the pseudohermaphrodite was in the normal female range, while 
that of the male was considerably below the female range of values.
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TABLE 18
DETERMINATION OF URINARY 17-DEOXYCORTICOSTEROIDS FROM
THE URINE OF NORMAL MALE, FEMALE AND MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Normal Male Normal Female Normal Pseudo
24 Hour Urinary 17-Deoxycorticosteroid Values
ug/24 hr pg/24 hr pg/24 hr









IXi 9.2 16.9 16 7
n
770.2 2,578.1 2,530.5
(ZXi)2 769.1 2,560.4 2,523.4
n
Sx 0.12 0.50 0.31
Steroid determinations were carried out on pooled 24 hour urine 
collections and individual rat values were calculated from the total 
alicuot.
8]
Likewise, Table 19 lists urinary 17-deoxycorticesceroid values of 27 
analyses of the urine of castrate pseudohermaphrodite and control rats. 
Figure 12 shows that these values do not differ significantly from those 
of normal rats.
Although administration of diethylstilbestrol depressed the 
urinary 17-ketosteroid output of adrenal origin in the pseudohermaphrodite 
rat, this did not establish whether the effect was due to gonadotropin 
suppression or simply to an adverse effect of diethyIstilbestrol on the 
adrenal. In order to clarify this point, determinations of 17-deoxycor­
ticosteroids were carried out on the urine of pseudohermaphrodites, and 
males and females during the course of diethylstilbestrol treatment.
The values listed in Table 20 for castrate pseudohermaphrodite and cas­
trate control rats demonstrated that adrenal function was not affected 
adversely by diethylstilbestrol. In fact, comparison of Figures 12 and 
13 shows that these values were slightly elevated during the course of 
stilbestrol treatment.
Histological Study
The adrenal glands of pseudohermaphrodite rats were studied his­
tologically to investigate the possibility of a correlation between ad­
renal. enlargement and zonation and an elevated adrenal production of 17- 
ketosteroids. Figure 14 illustrates a low power view of the pseudoher­
maphrodite rat adrenal in comparison with those of male and female con­
trols. The most obvious feature of the pseudohermaphrodite adrenal is a 
marked enlargement of an area in juxtaposition to uhe medulla. This area 
corresponds to the zona reticularis of the male and female adrenals.
Figures 15 through 23 illustrate the same adrenal glands at high
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TABLE 19
DETERMINATION OF URINARY 17-DEOXYCORTICOSTEROIDS FROM
THE URINE OF CASTRATE MALE, FEMALE AND MALE
PSEUDOHERMAPHRODITE RATS
Treatment Groups
Castrate Male Castrate Female Castrate Pseudo
24 Hour Urinary 17-Deoxycorticosteroids









11.8 17.5 17 3
IXi 10.8 16.4 17,5
n
1,062.3 2,424,0 2,760.3
1,058.2 2,408.2 2,743 7
n
Sx 0.24 0.47 0.49
Steroid determinations 
collections and individual rat
were carried out on pooled 2 
values were calculated from















Average Urinary 17-Deoxycorticosteroid Values Of Male,
Female And Male Pseudohermauhrodite Rats
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Figure 12. The above values represent an average of 9 
separate determinations. Each determination was carried out on a pooled 
24 hour urine collection and individual rat values were calculated from 
the value of the total aliquot-
TABLE 20
.DETESMINATION OF URINARY 17-DEOXYCORTICOSTEROIDS FROM
THE URINE OF STILBESTROL TREATED CASTRATE MALE,
FEMALE AND MALE PSEUDOHERMAPHRODITE RATS
Treatment Groups
Stilbestrol Treated Stilbestrol Treated Stilbestrol Treatec
Castrate Male Castrate Female Castrate Pseudo
24 Hour Urinary 17-Deoxycorticosteroid Val;jes








12.4 18 3 20:5
11.8 17.8 17.8





Sx 0.31 0.24 0.29
Steroid déterminât:ions were carried out on pooled 24 hour urine
collections and individual rat values were calculated ftorn the total alicuo
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Average Urinary 17-Deoxycorticosteroid Values of Male, Female
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Figure 13. The above values represent an average of 9 separate 
determinations. Each determination was carried out on a pooled 24 hour 
urine collection and individual rat values were calculated from the value 
of the total aliauot.
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Figure lA . CroKS-sccti.on of adrenal giands from male pseudoiiermaidirodi te (left), female (middle) 
and male (right) rats. Note the marked enlargement of an area adjacent to the medulla in tlie adrenal of 
tlie pseudohermaplirod 1 te. fills area appears broken up by sinusoids and corresponds to the zona reticularis 
of the female and male adrenals. Dclaficld's hematoxylin. X AO.
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Figure 15. Cross-section of an adrenal gland 
from a male pseudohermaphrodite rat showing both glomerul­
ar and fascicular zones. The zona fasciculata does not 
retain the radial symmetry found in the female and male 




Figure 17. Cross-section of an adrenal gland 
from a male rat showing both glomerular and fascicular 
zones. Note the radial symmetry of the zona fasciculata. 
Delafield's hematoxvlin. X 400.
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Figure 18. Cross-section of an adrenal gland 
from a male pseudohermaphrodite rat illustrating the 
reticulo-fascicular junction. The cellular cords ap­
pear to be disrupted by numerous sinusoids, an appear­
ance not found in the adrenals of males or females. 




Figure 19. Cross-section of an adrenal gland 
from a female rat showing the reticulo-fascicular 
junction. Note the symmetry of the cellular cords in 
the zona fasciculata. Delafield's hematoxylin. X 400.
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Figure 20. Cross-section of an adrenal gland 
from a male rat showing the reticulo-fascicular 
junction. Note the symmetry of the cellular cords in 
the zona fasciculata. Delafield's hematoxylin. X 400,
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Figure 21. Cross-section of an adrenal gland 
iron a nale pseudohermaphrodite rat. The section 
illustrates the rich sinusoidal vascularity of the 
zona reticularis. Delafield's hematoxylin. X 1000.
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Figure 22. Cross-section of an adrenal gland 
from a female rat showing the zona reticularis and 
parts of the medulla (upper right). Delafield's hema­
toxylin. X 1000.
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Figure 23. Cross-section of an adrenal gland 
from a male rat showing the zona reticularis (lower) 
and parts of the medulla (upper). Delafield's hema- 
toxvlin. X 1000.
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magnification. The outer zone or zona glomerulosa (Figures 15, 16, 17)
15 distinct with deeply staining nuclei and light basophilic cytoplasm
in all three adrenals. However, the middle or fascicular zone differs to 
some extent in the pseudohermaphrodite adrenal- In contrast to palisades 
of radial cellular cords found in the male and female adrenals (Figures
16 and 17), some areas of the fascicular zone in the pseudohermaphrodite 
adrenal are less symmetrical (Figure 15), Sinusoids appear to cut across 
cellular cords in these areas rather than coursing radially, while in 
other areas the radial symmetry is retained.
The most conspicuous changes are found in the zona reticularis 
of the pseudohermaphrodite adrenal. This area is characterized by en­
largement in thickness and increase in sinusoidal vascularity (Figures 
18 and 21). in addition, cellular cords are broken up by anastomosing 
sinusoids. Cells in this region recain a spongy appearance due to lipid 
extraction during fixation, an appearance normally restricted to the zona 
fasciculata. In short, these changes are indicative of increased meta­
bolic activity. Corresponding areas in the male and female adrenals re­
tain a radial symmetry, cell nuclei are compact and the cytoplasm stains 
acidophilic (Figures 29̂  20̂  22 and 23)- The above findings support the 
view that increased metabolic activity of the adrenal cortex in the pseu­
dohermaphrodite rat involves mainly the zona reticularis and furthermore, 
supports the view of a trophic stimulation by LH,
Summary of Experimental Findings 
The experimental findings demonstrated by the present study are 
as follows: _
1) The gonadotropin content of the pituitary and plasma of male
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pseudohermaphrodite rats was shown to be greater than that of male or 
female control rats.
2) Urinary 17-ketosteroid values in normal and castrate pseudo­
hermaphrodite rats were greater than corresponding values in male and fe­
male control rats. The testicular contribution accounted for more than 
one-half of the 17-ketosteroid value in the pseudohermaphrodite, and in 
addition, the adrenal contribution was found to be greater than that of 
male and female control rats.
3) Suppression of gonadotropic hormone secretion in the castrate 
pseudohermaphrodite rat resulted in a marked decrease in urinary 17- 
ketosteroids without affecting the 17-deoxycorticosteroid values.
4) Urinary 17-deoxycorticosteroid values in pseudohermaphro­
dite rats were found to be in the normal female range.
5) Comparative histological studies of adrenal glands from 
pseudohermaphrodite and control rats demonstrated enlargement of the zona 




The techniques employed will be appraised before presenting an 
interpretation of the resultsr
Appraisal of Methods
The Ovarian Ascorbic Acid Method for the Bioassay of LH
In the original description of this method, Parlow (1958; 1961) 
showed that anterior pituitary hormones other than luteinizing hormone 
(LH) were not active in the ovarian ascorbic acid depletion (QAAD) assay 
except in doses large enough to indicate contamination with LH Even 
when follicle-stimulating hormone (FSH), luteotropic hormone (LTH) or 
somatotropic hormone (STH) were added to LH, the response was not alter­
ed, thus indicating chat the method was reliable in the presence of a 
mixture of hormones. These results were confirmed by McCann and 
Taleisnik (1960), These investigators found that vasopressin will cause 
ovarian ascorbic acid depletion, but the quantities required were extreme­
ly large. Moreover, endogenous vasopressin release (evoked by hemorrhage 
in rats) did not result in depletion of ovarian ascorbic acid. Guiliani 
et al - (1961) reported that a variety of drugs and stress procedures 
were without effect in this test, Schmidt-Elmendorff and Loraine (1962) 
appraised the assay and concluded that it had the advantages of sensitivity
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and specificity, but a large proportion of the assays were invalid due 
to a lack of parallelism. The problem of non-linearity was also en­
countered in the present investigation which employed per cent depletion 
of ovarian ascorbic acid"and the slope-ratio form of regression analysis.
A variety of standard LH test materials were used by Persky and Norton 
(1964) to compare the stability of the dose-response relationship of 
the OAAD assay and the hypophysectomized rat prostate method. Both 
assays yielded stable slopes with all standards, but the OAAD method was 
recommended because of its greater sensitivity.
Significant diurnal variation in ovarian ascorbic acid content of 
rats prepared for bioassay has been demonstrated by Stevens _ê  al. (1964). 
Likewise Lawton and Schwartz (1965) demonstrated a 24-hour periodicity in 
ovarian ascorbic acid to standard doses of LH. Both groups recommended 
that OAAD assays begin at a standard time each day, preferably in the 
morning when ascorbic acid levels are high, in order to minimize this 
effect. Thus, despite some limitations, the OAAD assay is generally ac­
cepted as a convenient and sensitive method for the assay of LH potency 
in pituitary extracts. The OAAD method for estimating plasma LH activity 
employed in the present study either underestimated or overestimated the 
actual potency because of curvilinear regression lines. Statistical 
validity was determined by testing for deviation from regression. Those 
assays which showed significant deviation from regression were considered 
statistically invalid. Consequently, only inferences involving differences 
between experimental groups can be made, since the relative potencies are 
estimated from non-linear regression lines. Figures 4 and 8 show a greater 
pituitary and plasma LH potency for pseudohermaphrodites when the dose 
levels employes are considered.
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The Method of Parabiosis for the Bioassay of FSH 
Investigators have used many methods to quantitate follicle- 
stimuiating hormone (FSH) from extracts of the anterior pituitary.
Evans ^  â . (1939) used histological criteria based on the production 
of non-atretic follicles with small antra in the ovaries of hypophysecto­
mized 21-day old female rats. In addition, increase in uterine weight 
was employed by the above investigators as an endpoint for the estimation 
of FSH activity. Fevold, Lee, Hisaw and Cohn (1940) demonstrated the 
effectiveness of an increase in ovarian weight in the immature 21-day 
old female rat as an assay procedure for FSH. Creep, Van Dyke and Chow 
(1940) utilized the increase in testicular weight, in the absence of pro­
state and seminal vesicle hypertrophy. Steelman and Pohley (1953) employ­
ed the increase in ovarian weight when the ovary was synergized with hu­
man chorionic gonadotropin, while Payne, Runser and Hagans (1959) recom­
mended the increase in ovarian weight following augmentation with stil- 
bestrol for estimation of FSH potency. The last two methods are the most 
sensitive, but are effective only for pituitary extracts and not for 
plasma.
Radio-immunological assays have been shown recently to be sensi­
tive to plasma levels of gonadotropins (Faimen and Ryan, 1967). These 
methods depend on a reaction between hormone labeled with 1-131 (labeled 
antigen) and an antibody specific to the hormone. This reaction results 
in the formation of a labeled antigen-antibody complex. If unlabeled 
hormone is added it competes for the fixed amount of antibody and forms 
an unlabeled antigen-antibody complex, thereby reducing the amount of 
antibody which can participate in the formation of the labeled complex.
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Thus Che ratio of 1-131 hormone bound to antibody to the free 1-131 hor­
mone falls progressively in proportion to the increase in concentration 
of the unlabeled hormone. The major criticism of the radio-immunological 
assay deals with the fact that other anterior pituitary hormones crcss- 
react with the antibodies for the gonadotropins.
The use of parabiosis in the present study has the disadvantage 
of demonstrating only elevated titers of FSH. In addition, the results 
are not quantitative in nature. However, the assay did demonstrate an 
elevated FSH titer in the pseudohermaphrodite rat as evidenced by an in­
crease in ovarian weight of female parabionts. Normal plasma titers of 
FSH were readily metabolized by control animals and therefore significant 
amounts of FSH did not enter the circulation of the test animals. In the 
case of the pseudohermaphrodite, FSH titers were so high that signifi­
cant quantities did enter the circulation of the test parabiont and 
stimulated ovarian enlargement.
Determination of Total Neutral Urinary 17-Ketosteroids 
All 17-ketosteroids have in common an oxygen atom attached at C^_ 
and all are derivatives of two parent hydrocarbons, 5a-androstane and 
53-androstane, which differ only in the spatial configuration or the 
hydrogen atom at C-. Epiandrosterone and dehydroepiandrosterone are the 
principal 17-ketosteroids with the 3S-hydroxy group. However, the major 
portion of the total urinary 17-ketosteroids show the 3a-hydroxy con­
figuration (Loraine and Bell, 1966). From a quantitative standpoint the 
two most important compounds in this fraction are androsterone and etio- 
chclanolone. The estrogenic steroid estrone is also a 17-ketosteroid
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However, this compound, due co its phenolic A ring, is acidic in nature 
and IS removed from urinary extracts when these are washed with a base.
As a result of reactions which occur during the process of hydroly­
sis and extraction, a number of chemical changes called artifacts are pro­
duced in the steroids of urine (Dcrfman and Shipley, 1956). The produc­
tion of these artifacts may distort the true values of the urinary ste­
roids by causing an apparent increase or decrease in the concentration 
Artifacts arise as a result of reactions of substitution, dehydration, 
rearrangement or epimerization occurring during the process of hydroly­
sis and extraction (Dorfman and Shipley, 1956). Under special circum­
stances, these artifacts can be extinguished by various correction for­
mulae- In the present study, the best results were obtained by correct­
ing the unknown with a urine blank and calculating the unknown value from 
a calibration curve. Per cent transmittance was employed in the construc­
tion of calibration curves rather than absorbance, because small changes 
in concentration at the upper end of the transmittance scale result in 
relatively large changes in transmittance, but only small changes in 
absorbance- This is due, in part, to the difficulty in reading absorbante 
from a logarithmic scale and also to the exponential increase in trans­
mittance with arithmetically increasing concentrations - The transmit­
tance scale is linear over the entire range, but per cent transmittance 
measurements cannot be used for direct calculation of unknown concentra­
tions, since transmittance increases or decreases exponentially. How­
ever, by plotting the logarithm of transmittance against concentration, 
a linear relationship is obtained and a direct proportion can be used in 
the calculation of unknown values- Thus, the linearity of the calibration
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curve was improved at the lower ranges of concentration by using trans­
mittance. Despite the obvious limitations of the method employed for the 
determination of urinary 17-ketosteroids, results were consistent. The 
method was able to demonstrate differences in males, females and pseudo­
hermaphrodites and differences following castration, and stilbestrol and 
dexamethasone treatments. Finally, the specificity of the method and 
magnitude of the results obtained in the present work were corroborated 
by plasma determinations of steroids from pseudohermaphrodite rats re­
ported by Stanley and co-workers (1967), These results are listed in 
APPENDIX II, page 136).
Determination of Urinary 17-Deoxycortlcosteroids 
The methods available for the group determination of 17-deoxycor- 
ticosteroids are limited in number and lacking in specificity Attempts 
at the group determination of urinary 17-deoxycorticosteroids on form- 
aldehydrogenic substances proved unsuccessful, when it was shown that 
cortisone and other 17:21 diol-20-ones significantly contributed to the 
determination (Tompsett, 1953). The method employed in the present 
work IS considered specifically to determine 17-deoxycorticosteroids 
which on consecutive treatment with borohydride and with sodium bismu- 
thate yield non-volatile aldehydes (Exley, e_t , 1961). The excellent 
correlation found between the excretion of 17-deoxycorticosteroids by 
normal untreated rats and by those whose adrenal function was suppressed 
by treatment with dexamethasone indicates adrenal origin of the compounds 
determined by the present method.
One of the primary criticisms directed against the method of 
aldehyde conversion for the determination of urinary 17-deoxycorticoster- 
oids was stated by Exley and co-workers (1961) in their original
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description of the procedure. These investigators were able to show that 
large and variable reagent blanks resulted from surplus benzenesulpho- 
hydroxamic acid and formed sulphinic acid. However, when the formed 
hydroxamic acid was extracted with ethyl acetate, the interfering sub­
stances remained in the aqueous phase. Exley _et al. ,(1961) demonstrated 
that the ferric hydroxamate complex could be concentrated by adding pe­
troleum ether to the ethyl acetate extract. This procedure quantitative­
ly transferred the complex from the organic to the aqueous phase*
Interpretation of Results
Gonadotropin Assays 
Evidence of a relationship between gonadotropins, particularly LH, 
and the adrenal was assembled by Reifenstein e£ (1945), Albright (1947), 
and Jones (1948). With the lapse of more than 20 years, the evidence 
has not been sufficiently substantiated to warrant a general theory- In 
a few species of animals there are seasonal changes in the reticular zone 
of the adrenal with particular reference co the sexual cycle (Zalesky,
1934). These few reports constitute the basis for the previously held 
notion which considered the gonadotropins to be tropic to the zona retic­
ularis of the adrenal gland. The above reports have been criticized so 
severely th&t the relationship between gonadotropins and adrenal cortex 
has gone essentially uninvestigated for more than 20 years.
The present study has reopened the question of the relationship 
of the gonadotropins to the adrenal cortex with new evidence accumulat­
ed from experiments conducted on male pseudohermaphrodite rats- Among 
the various points considered is the status of the gonadotropin titer in
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the male pseudohermaphrodite rac- These animals exhibii a chronic high 
Liter of LH both in the pituitary gland and plasma (Figure 4 and 8, Pages 
50,67). Indeed, this very finding makes the entire study unique because 
the adrenal cortex of these animals is under the continuous- influence of 
a high gonadotropin titer. A similar condition may be mandatory for the 
demonstration of androgenic stimulation in the absence of increased cor­
ticosteroid production in normal animals. The pseudohermaphrodite rat 
has a pituitary LH potency considerably greater than that of normal male 
and female rats, A high pituitary content of LH is associated generally 
with an increased secretory output. This is reflected in the findings 
from normal male and female rats. The male rat has a larger pituitary 
LH content and also a higher plasma titer of LH than does the female. 
Although interpretation of plasma results was difficult in the present 
study, plasma LH assays did demonstrate an elevated LH titer in the 
pseudohermaphrodite rat in comparison to that of male and female controls.
The gonadotropin titer in the pseudohermaphrodite rat was charac­
terized further with the finding of an increase in the FSH fraction 
(Figure 9, Page 70)- This finding was reflected in an increased ovarian 
weight of female rats united in parabiosis with pseudohermaphrodites 
Although these results cannot be quantitated, they do demonstrate that 
either FSH is not metabolized by the pseudohermaphrodite rat, or that 
the FSH titers are markedly elevated due to an increased pituitary secre­
tion. The finding of a low pituitary FSH content in the pseudohermaphro­
dite rat pituitary supports the latter view (Easley, 1966). The signifi­
cance of an elevated plasma FSH in relation to adrenal function is not 
as readily explained as that of LH, but certainly synergism between FSH
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and LH is known to exist with respect to gonadal function. In summary, 
the findings discussed in this section substantiate the first condition 
of the working hypothesis; namely, gonadotropin titers are elevated in 
ihe male pseudohermaphrodite rat.
Urinary 17-Ketosteroids 
Acute experiments employing bolus injections of gonadotropins, 
exemplified by the work of Gemzell, Diczfalusy and Tillinger (1958), and 
Apostalokis, Bettendorf and Voigt (1962), have failed to demonstrate 
significant increases in urinary 17-ketosteroids. These findings are not 
surprising when the half-life of gonadotropin preparations are taken in­
to account. In all probability, a continuous chronic presence of gonad­
otropins is necessary before the adrenal cortex becomes responsive to 
tropic stimulation. Three methods could be employed to meet the above 
conditions: in vitro incubation of adrenal slices with gonadotropins,
perfusion of the adrenal with gonadotropins or a long-acting gonadotropin 
preparation. The male pseudohermaphrodite rat is a good experimental 
model, since the continuous high gonadotropin output in these animals 
produces chronic stimulation of the adrenal cortex.
Baseline values for the 24-hour urinary 17-ketosteroid excretion, 
established by the present study, demonstrated a urinary output in the 
pseudohermaphrodite rat 3 to 5 times greater than that of male or female 
controls (Figure 10, page 74). The adrenal and testicular contributions 
to the 17-ketosteroids were assessed by déterminâtions"carried out on 
castrate animals. Values of urinary 17-ketosteroids from castrate ani­
mals were considered to be entirely of adrenal origin. Accordingly, the
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testes were found to contribute more than one-half of the normal value 
in the pseudohermaphrodite and, in addition, the adrenal contribution was 
shown to be considerably above that of male or female control rats. The 
marked contribution of the testes to the 17-ketosteroids in the pseudo­
hermaphrodite was reflected in the hyperplasia of the Leydig cells of 
these gonads. This was interpreted to be the result of an increased quan­
tity of LH acting on the interstitial cells. Likewise, an increased ad­
renal contribution has been attributed to the high circulating titer of 
LH.
Several lines of evidence suggest that the adrenal cortex of the 
pseudohermaphrodite is stimulated by LH. It will be recalled from a 
previous section (Page 10) that the adrenals of the pseudohermaphrodite 
are significantly larger than those of males and females of the same 
age (APPENDIX II, page 135). This suggests some kind of increased meta­
bolic activity, but does not indicate the mediator. On the assumption 
that LH was the mediator of adrenal enlargement and increased testicular 
and adrenal androgen production, experiments were conducted whereby pit­
uitary gonadotropin secretion was suppressed by treatment with diethyl- 
stilbestrol. Coincident with gonadotropin suppression, the 17-ketoster­
oids of the pseudohermaphrodite rat fell considerably below the castrate 
values (Figure 11, page 78). This finding indicated that both testicular 
and adrenal function were dependent on the previously existing levels of 
LH. Stilbestrol treatment of male and female rats resulted in a moderate 
depression of 17-ketosteroids in the male, while the female values were 
essentially unaffected.
The adrenal function was assessed independently of the gonads by 
treating castrate pseudohermaphrodites w i t h  d ie th yl st il be st ro l . Again,
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the 17-ketosteroids fell below the castrate values, indicating a previous 
stimulation by LH. Adrenal function in relation to 17-ketosteroid pro­
duction was not totally dependent on a tropic stimulation by LH, because 
gonadotropin suppression decreased the values only to the normal female 
range. Thus the greater part of the adrenal contribution in the pseudo­
hermaphrodite was probably mediated via ACTH, as in the case of the male 
and female rats. The relationship between ACTH and LH was further demon­
strated by results from experiments in which adrenal function was suppress- 
"ed'with dexamethasone. Under dexamethasone treatment, the 17-ketosteroid 
output in the pseudohermaphrodite fell to one-fifth of the normal value, 
while 17-ketosteroids were undectable in both male and female controls.
The same experiments conducted on castrate pseudohermaphrodites completely 
abolished 17-ketosteroid production. Thus, in addition to completely ab­
olishing the adrenal contribution, the testicular output of 17-ketosteroids 
was depressed by dexamethasone. It is concluded from these results that 
LH is effective only when adrenal function is maintained by ACTH.
A final line of evidence which suggests that the pseudoherm.aphro- 
dite adrenal is influenced by LH comes from the histology of the adrenal. 
The relationship between LH and the zona reticularis of the mouse and 
thirteen-lined ground squirrel has been previously discussed (Zalesky,
1934; Jones, 1948). In this connection, the adrenal of the pseudohermaph­
rodite rat shows hypertrophy of the zona reticularis (Figure 14, Page 
86). Thus the physiological data are supported by anatomical findings.
17-Deoxycorticosteroids
The striking enlargement of the pseudohermaphrodite adrenal gland 
(30% larger than that of control rats) gave rise to numerous speculations
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regarding the cause of its enlargement. Evidence seemed insufficient to 
suggest a cause for enlargement consistent with the well-established con­
cepts of adrenal function. The commonly accepted view concerning adrenal 
function holds that adrenocorticotropin (ACTH) is the sole pituitary fac­
tor which can mediate increased metabolic activity of the adrenal cortex. 
Increase in adrenal function generally arises as the result of one of the 
following conditions: autonomous hyperfunction such as is found in tum­
orous conditions of the adrenal, increased tropic stimulation by ACTH 
due to a pituitary neoplasm, or increased tropic stimulation by ACTH in 
association with insufficient negative feedback on the hypothalamo- 
hypophyseal axis. Any of these conditions would impair the health of an 
affected individual, a situation not seen in the pseudohermaphrodite 
rat.
The possibility of ACTH being the mediator of adrenal hyperfunc­
tion in relation to 17-ketosteroid production was obviated in the present 
study by the demonstration of 17-deoxycorticosteroid values in the pseudo­
hermaphrodite rat within the normal female range (Figure 12, page 83).
Both pseudohermaphrodite and female 24-hour urinary 17-deoxycorticosteroid 
values were considerably above those of normal males, a finding further 
reflected in the small adrenal weight per 100 grams body weight and low 
17-ketosteroid output of the normal male rat. It is unlikely that ACTH 
could mediate an increase in androgen production without causing a con­
comitant increase in the corticosteroid production. Conversely, LH does 
stimulate 17-ketosteroid production, but not 17-deoxycorticosteroids and 
is therefore considered to be the tropic factor involved.
Previous mention has been made of the fall in 17-ketosteroid
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production of the castrate pseudohermaphrodite following gonadotropin 
suppression. However, these experiments failed to establish whether the 
effect was due to gonadotropin suppression or to an adverse effect of 
stilbestrol on the adrenal. The latter possibility was examined experi­
mentally by analyses of 17-deoxycorticosteroids in the urine from ani­
mals during stilbestrol treatment. Results from these experiments in­
dicated that the 17-deoxycorticosteroid production was slightly increas­
ed during stilbestrol treatment. If stilbestrol was acting adversely on 
the adrenal, the effect was not reflected in the corticosteroid values.
It seems unlikely that stilbestrol could suppress the 17-ketosteroids 
without having a similar effect on the corticosteroid production. These 
results support the interpretation that a fall in adrenal 17-ketosteroids 
in the pseudohermaphrodite rat is due to a suppression of the tropic sti­
mulation by LH.
Histological Findings 
In 1938, Howard described a special area in the adrenal of the 
new-born rat characterized by a poorly demarcated zone of cells at the 
cortico-medullary boundary which disappeared in both sexes with increas­
ing age. It was removed, not by degeneration, but by transition into 
the adult reticular zone. The period during which the rat juvenile cor­
tex is prominent bears a close relationship to certain changes in male 
accessory sex organs. Castration of male rats more than 30 days of age 
was followed by regressive changes in the prostate and seminal vesicles. 
Castration during the first week of life, however, was not followed by 
these changes, but instead, the accessory organs continued to grow.
Howard (1938) interpreted these findings to mean that the juvenile
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3) Corticosteroid production in the pseudohermaphrodite is com­
parable to and in the range of that of female controls.
4) Suppression of gonadotropin secretion decreased adrenal 17- 
ketosteroid production in the pseudohermaphrodite without affecting the 
corticosteroid values.
These findings indicate that the cause of adrenal enlargement 
and hyperfunction of the adrenal androgen biosynthetic pathway in the 
male pseudohermaphrodite rat is due to a tropic stimulation of the adren­
al cortex by an elevated titer of pituitary gonadotropins.
CHAPTER V
SUMMARY
The rationale for the approach of the present study was based on 
a working hypothesis which considered the gonadotropic hormones, primar­
ily LH, to be tropic to the adrenal cortex of the male pseudohermaphro­
dite rat. This hypothesis was based on numerous preliminary findings, 
including adrenal enlargement, increased plasma 17-ketosteroids, indica­
tions of an elevated titer of gonadotropins (Leydig cell hyperplasia) 
and absence of Cushingoid pathology. Accordingly, four conditions were 
set forth to test the validity of the hypothesis based on the effects 
expected from a tropic stimulation of the adrenal by LH. The present 
study has fulfilled all requirements of the experimental design in the 
findings listed below:
1) Bioassay of the gonadotropin content (LH and FSH) of pituit- 
aries and plasma of male pseudohermaphrodite rats has demonstrated great­
er relative potencies, when compared with NIH reference standards, than 
corresponding potencies of male or female rats.
2) Determinations of the 24-hour urinary 17-ketosteroid excre­
tion in pseudohermaphrodites and control rats demonstrated a value in the 
pseudohermaphrodite 3 to 5 times greater than values for control rats.
The testicular contribution accounted for more than one-half of the 17- 
ketosteroids in the pseudohermaphrodite, and in addition, the adrenal
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contribution was found to be greater than that of male or female control 
rats.
3) Suppression of gonadotropic hormone secretion in the castrate 
pseudohermaphrodite rat resulted in a sharp decrease in urinary 17-keto­
steroids without affecting the 17-deoxycorticosteroid values. This find­
ing was interpreted to mean that the pre-treatment values of 17-keto­
steroids were partially dependent on a tropic stimulation by LH. Further­
more, the relationship between ACTH and LH with respect to adrenal func­
tion was shown by the fact that 17-ketosteroid production was abolished 
when ACTH secretion was suppressed by dexamethasone treatment. It is 
concluded that the tropic influence of LH on the adrenal is dependent
on A C T H  for maintenance of adrenal function.
4) Determinations of urinary 17-deoxycorticosteroids in the 
pseudohermaphrodite rat produced values in the normal female range. This 
finding indicated that ACTH was not the mediator of increased adrenal 
17-ketosteroid production, since corticosteroid values were not elevated.
In addition to the above experimental findings, comparative 
histological studies of the adrenal glands of pseudohermaphrodite and 
control rats revealed enlargement of the zona reticularis and increased 
sinusoidal vascularity in the adrenal of the pseudohermaphrodite. Sim­
ilar histological findings have been observed in the mouse and thirteen- 
lined ground squirrel after administering gonadotropic preparations 
(Zalesky, 1941; Jones, 1948). Hence the histological make-up of the 
pseudohermaphrodite adrenal supports the physiological data and indicates 
that enlargement of the zona reticularis is due to a tropic stimulation 
by LH.
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In view of the findings presented in this dissertation, it is 
concluded that adrenal enlargement and increased 17-ketosteroid produc­
tion of the adrenal glands of the male pseudohermaphrodite rat is due 
to a tropic stimulation by an increased titer of gonadotropins.
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The above illustration shows the phenotypic 
make-up of a male pseudoherm:aphrodite rat. Note the 
mammary line and vaginal orifice. The bilateral pro­
trusions on each side of the vagina are testes which 





Cross-section of a testis from a male pseudo- 
hermaphrodite rat showing spermatogonia, large primary 
spermatocytes and Sertoli cells. Note the absence of 
secondary spermatocytes, spermatids and spermatozoa. 
Hematoxylin and eosin. X 1200.
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m
Cross-section of a testis from a male pseudo- 
hermaphrodite rat showing hyperplasia of the interstitial 
cells. Hematoxylin and eosin. X 400.
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Section through a Sertoli cell tumor from the 
testis of a male pseudohermaphrodite rat shoving numer­
ous Sertoli cells. Hematoxylin and eosin. X 1200.
133
y
Section through a Sertoli cell tumor from the 
testis of a male pseudohermaphrodite rat. This area 
bears no resemblance to the parent tissue. Hematoxylin 
and eosin. X 1000.
APPENDIX II
AVERAGE BODY AND ORGAN WEIGHTS AND AVERAGE PROPORTIONAL WEIGHTS OF ORGANS WITH CALCULATED 
STANDARD ERRORS OF THE MEANS OF FEMALE, MALE AND MALE PSEUDOHERMAPHRODITE RATS











limais Sex Mos . mg . mg . mg. mg. mg. mg, mg.
15 3- 6 222 + 4 45 + 2 223 + 18 14.5 + .12 13.5 ± .13 1,597 ±  50
15 6-12 239 6 41 + 2 85 + 6 16.5 + .18 14.3 + . 2 1,742 + 48
15 cf 3- 6 358 + 16 44 + 2 280 + 23 18.3 + . 66 10. 0 + .37 3,105 + 179 2,516 +109
15 6-12 414 + 11 38 + 2 123 + 9 21.5 + 1.0 11.1 + .1 2,953 + 77 2,787 ±  55
15 3- 6 292 + 12 62 + 2* 323 + 35 16.3 + . 7 14.9 . 7* 956 + 45* 1,796 + 64'
15 6-12 317 + 12 57 ± 3* 126 + 11 18.3 + 1.4 17.2 + .9* 679 + 45* 1,936 ±  76
AVERAGE PROPORTIONAL ORGAN WEIGHTS (mg/IOO gin body weight)
15 3- 6 222 ± 4 21 + .81 101 + 9 6.5 + .14 6.1 + .17 720 + 14
15 6-12 239 + 6 17 + . 4 6 36 + 2 6.9 + . 21 6.0 + .25 728 + 8
15 d* 3- 6 358 + 16 12 + .43 81 + 3 5.2 + .20 2.8 + .25 885 + 11 704 + 11
15 6-12 414 + 11 9 + .34 30 + 2 5.3 + .23 2. 71+ .086 719 + 19 679 + 12
15 f 3- 6 292 + 12 22 + .70* 119 + 13 5.6 + .15 5.1 + .14* 330 + 13* 617 + 11*
15 6-12 317 4- 12 18 + . 66* 40 + 3 5.7 4- .37 5.4 + .24* 218 + 16* 610 + 20*
OJLn
Significantly different, to the .01 level, from males of same age.
STEROID DETERMII^ATIONS OF PLASMA .FROM NORMAL MALE 
AND MAT.E PSEUDOlIERMAl'URODITE RATS
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Ca3 cu3 atlons of Steroid have been reported In tlie nearest whole number of pg! a31 
calculations are based on perceirtage recovery of steroid added to control rat plasma.
